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SAMMENDRAG 
 
Forebyggende medisin har et potensial for å gjøre livene våre bade bedre og verre. I denne 
avhandlingen presenteres refleksjoner rundt denne situasjonen, støttet av empirisk forskning. 
Utgangspunktet for refleksjonene er forskerens sosialkonstruksjonistiske posisjon. 
Refleksjonene gis rundt tre sammenhengende tema – risikobegrepet i medisinen, 
medikalisering og osteoporose. 
 
Studien er basert på seks delstudier gjennom anvendelse av ulike kvalitative metoder. Den 
omfatter data fra medisinske litteraturdatabaser, avisartikler og fokusgrupper. 
 
Blant funnene i studien er risikoepidemien i den medisinske litteraturen som har nådd en 
foreløpig topp det siste tiåret. Videre er utviklingen av den medisinske forståelsen av 
osteoporose blitt studert, hvilket viser at medisinsk teknologi har bidratt til å omgjøre 
osteoporose til en risikofaktor tilgjengelig for risikoreduserende intervensjoner. 
Introduksjonen av slike intervensjoner gjennom medisinsk behandling var gjenstand for 
kontroverser, og kontroversene er analysert gjennom avisdekningen av hva som i ettertid er 
kjent som Fosamax-saken. Kunnskap om osteoporose blant kvinner i Nord-Trøndelag viser 
seg å være grunnlagt i deres hverdagserfaringer, hvor fall på glattisen er blitt lakmustesten på 
om de har osteoporose. Opplevelsen knyttet til screening for osteoporose viser derimot at den 
medisinske definisjonen av osteoporose gir liten mening for dem. Variasjoner i 
risikokategoriseringer og måleteknologi bidro til forvirring om måleresultatene, hvilket også 
formidling av måleresultater i form av standardavvik bidro til. I den siste delstudien 
reflekteres det over hvordan patologiseringen av normalitet gir muligheter for en potensielt 
grenseløs medikalisering. 
 
Funnene viser at moderne informasjonsteknologi paret med den medisinske risikoforståelsen 
har lagt grunnlaget for hverdagslivets medikalisering. Medikalisering av osteoporose 
beskrives som å forekomme på tre ulike måter, gjennom hverdagslivets medikalisering, 
gjennom medikaliseringen av menopausen og den spesifikke medikaliseringen av osteoporose. 
Bentetthetsmålinger beskrives som en viktig ingrediens i medikaliseringen av osteoporose, 
sammen med tilgangen til forebyggende medisinsk behandling. Nye utviklinger på området 
åpner imidlertid for muligheten for at benmassemålinger i framtida kan komme til å spille en 
mindre rolle. Blant begrensningene for medikaliseringen av osteoporose er det som i 
medisinske termer omtales som manglende risikobevissthet og kunnskap om osteoporose, 
samt motvilje mot å ta medisiner mot osteoporose. Disse begrensningene er imidlertid ikke 
intenderte, i motsetning til motstanden mot medikaliseringen av menopausen. Konsekvensen 
av screening for osteoporose er at den har en beroligende virkning blant de kvinner som får 
vite at benmassen deres er OK, mens den for andre blir en kilde til forvirring. For noen blir 
den også et bevis på den skjøre tilstanden kroppen deres er i. 
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ABSTRACT 
 
Preventive medicine comes with the potential for making our lives both better and worse. In 
this thesis reflections around this situation are offered, supported by empirical research. The 
reflections are offered from a social constructionist position. Three themes are covered – the 
concept of risk in medicine, medicalization and osteoporosis.  
The study is based on six sub-studies applying a mix of qualitative methods. It covers data 
sets from medical literature databases, newspaper articles and focus groups. 
Among the findings of the study is the risk epidemic in medical literature, which has hitherto 
been found to peak in the first decade of the 21st century. Furthermore, the development of the 
medical understanding of osteoporosis has been traced, showing how the introduction of 
medical technology transformed it into a risk factor available for risk reducing interventions. 
The introduction of such reductions through chemoprevention was subject to controversy, and 
this controversy has been analysed through the newspaper coverage of what became known as 
the Fosamax-case. Knowledge of osteoporosis among women in Nord-Trøndelag has 
furthermore been shown to be based on everyday experiences wherein falling has become the 
ultimate test of osteoporosis. The experience of screening for osteoporosis among the same 
women illustrates that the medical definition of osteoporosis made little sense to them. 
Variation in risk categorization and measurement technology contributed to confusion over 
the test outcomes, as did the communication of test results as standard deviations. In the last 
paper reflections are offered on whether the pathologization of normality presents a 
possibility for unlimited medicalization. 
These findings show how modern information technology paired with the idea of risk in 
medicine has prepared the ground for the medicalization of everyday life. The medicalization 
of osteoporosis is described as happening three times over, through the medicalization of 
everyday life, the medicalization of menopause and the specific medicalization of 
osteoporosis. Bone density measurements are described as a crucial ingredient in the 
medicalization of osteoporosis, alongside chemoprevention. Recent developments show that 
bone density measurements may come to play a minor role in the future, however. Among the 
limits of medicalization are what in medical terms is described as lack of risk awareness and 
knowledge of osteoporosis, alongside a reluctance to take chemoprevention as a measure for 
reducing the risk of fractures. These limits to medicalization are unintended, however, unlike 
earlier feminist resistance against the medicalization of menopause. The consequences of 
screening for osteoporosis show that it has a reassuring effect on the women told that their 
bone density is OK, whereas for others it is a source of confusion. For some it also has the 
effect of demonstrating the frailty of their bodies. 
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THESE ARE STRANGE TIMES, WHEN WE ARE HEALTHIER  
THAN EVER BUT MORE ANXIOUS ABOUT OUR HEALTH. ACCORDING 
TO ALL STANDARD BENCHMARKS, WE’VE NEVER HAD IT SO HEALTHY. 
- Roy Porter –  
 
INTRODUCTION 
Among many other things life confronts us with problems. What the problems are and how 
they are dealt with is influenced by the time we live in, the fabric of our society, what 
generation we belong to, and what features define us as individuals. Some of these problems 
are perceived as health problems, diseases even, for which medical help can be found. When 
we seek this help we have accepted that they are medical problems, falling within the realm of 
biomedicine. When we take the time to reflect about this common situation, which many of us 
have come to take for granted, a possible outcome of the reflection might be the sneaking 
recognition that it could have been different. 
 Acknowledging that things could have been different, we may realise that there is little 
room for determinism and simple cause-effect relationships. When simplicity is replaced by 
complexity, we may come to realise that uncertainty prevails. In the face of uncertainty 
people will live their lives hoping for the best and fearing the worst. This has been, and will 
continue to be, a significant part of the human experience. In modern society, however, this 
experience is also different in important ways from that of our ancestors. The difference is 
related to the impact of science and technology. One such impact has come through the notion 
of risk, which has contributed to making us more aware of the potential dangers in our 
everyday life.  
Another facet of the notion of risk is also that we are no longer at the total mercy of 
fate, but that science and technology can also be seen as having gifted us an increased ability 
to control our fate. Such control seems to require that we accept that medical interventions 
can be implemented on individuals who perceive no symptoms of disease themselves. For 
some this is an unhealthy sign of medical imperialism, whereas others see this as a major 
improvement of the human condition. Whatever the interpretation, besides solving some of 
our problems, the present situation is also creating some new ones. Being provided the option 
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of choosing, gifts us the problem of making the right choice, which calls for further 
reflections. 
 This thesis is the product of such reflections, supported by empirical research.  
 
Overall aim of the study 
The overall aim of this thesis is to offer critical reflections on preventive medicine. For a long 
time I believed that this could be done by answering the question ‘for better or for worse?’ 
My reflections have taught me, however, that this is an impossible question to answer. Instead 
I have come to realise that preventive medicine does not come with the option of choosing 
between good and evil, but rather with the option of balancing good and evil. Like a partner in 
marriage, you accept that you will come to live with his/her good sides and bad sides. Hence, 
the title - ‘for better, for worse’. 
A characteristic of modern medicine is that it is easily portrayed in extreme terms, as 
an activity offering both miracles and disasters. This is also illustrated by the contrasting titles 
of scholars like Porter (1997) and Illich (1976), who have indicated that medicine can be ‘the 
greatest benefit to mankind’ and a ‘nemesis’ in modern society, respectively. It is within this 
love/hate relationship with modern medicine that this thesis is placed.  
Looking beyond the outliers of miracles and disasters in modern medicine there is a lot 
of medical knowledge and practice that is more challenging to analyse and categorize. One of 
these areas is the recent developments in preventive medicine, in particular the part that is 
preoccupied with the concept of risk. Preventive medicine can on the one hand be seen as 
making things better, summed up in Geoffrey Rose’s (1992:4) humanitarian argument “It is 
better to be healthy than ill or dead.” As with other well intended pursuits, preventive 
medicine has its downsides, however, which has led some to raise the question whether there 
is a pathology of prevention when people feeling perfectly healthy are being told that they are 
at risk of a potentially serious and fatal disease (Sachs, 1995). Acknowledging the disaster 
potential of interventions at the population level, Skrabanek (1990) questioned the ethical 
status of preventive medicine. Similar sentiments have been expressed by Rosenberg 
(1997:45):  
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“With our increasing diagnostic capacities, we have provided altered narratives for millions of 
individuals who might otherwise have lived out their lives in ignorance of a nemesis lurking in their 
bodies.” 
The status of preventive medicine has in recent times also been characterised as morally 
problematic as it is contributing to medicalization (Verweij, 1999). Among Verweij’s 
concerns is the possibility that it erodes people’s confidence in their own health, as the 
cumulative offering of various screening tests may serve as a constant reminder of the frailty 
of their bodies. In addition he questioned the attributions of responsibility that can be made in 
relation to preventive medicine and health promotion.  
Furthermore, this dissertation is inspired by the question posed by Roy Porter (1997:3-
4): 
“Have we become health freaks or hypochondriacs luxuriating in health anxieties precisely because we 
are so healthy and long-lived that we have the luxury of worrying?” 
As it is hard to believe that Porter saw health freaks and hypochondriacs as honorary titles, it 
seems a fair interpretation to think that he posed this question from a critical angle. It is as 
much an observation as a question, reflecting the relativity of our present situation. 
A similar observation was made by LeFanu (1999) who described the worried well as 
one the paradoxes of modern medicine. He also observed that this situation was brought upon 
the population as they are consistently told about threats to their lives. In his words this has 
happened because people ‘have been led to believe’ (p. XIX) certain things. His choice of 
words is interesting, as there are numerous implications attached. 
 One such implication relates to reality and our perception of it. When somebody is led 
to believe something, this something may be different from that which is true, indicating that 
people are led to believe in a distorted reality. Such deceiving powers have been attributed to 
the pharmaceutical industry (Angell, 2005). Another implication is that somebody has the 
power to lead others, who are willing to be led. In health matters this power has been 
attributed to the medical profession, through what is known as medicalization – ‘a process by 
which human problems come to be defined as medical problems.’ (Sadler, et al. 2009).  
 LeFanus’s assumption and its implications call for a critical reflection, which will be 
offered on such phenomena as risk, medicalization and osteoporosis in the presentation of the 
14 
 
theoretical perspectives behind this thesis. By offering my critical reflections I lean on Martin 
Hammersley’s (2005) description of the role of the critical social scientist. In this thesis I will 
critically examine medical research and knowledge, in an effort to challenge its validity. As 
the goal of medicine is to benefit humanity, I will problematize whether that is what is 
actually happening. In accordance with Hammersley’s prescription I will try to do so 
prudently, as the field of study is a complex one. As a consequence of this prudence critical 
reflections will also be offered on the theoretical perspectives applied in this thesis. 
 The presentation of these reflections will in part be done through what has been called 
methodology-as-autobiography (Hammersley, 2011), acknowledging the central position of 
the researcher in the research that is to be presented. 
 
Aims of the sub-studies 
This study is by no means the outcome of the successful pursuit of following a master 
plan. Rather, it is the result of a journey where new questions have been discovered along the 
road, questions that have led to new reflections. In academic terms it may be described as the 
outcome of an explorative design, where most of the research questions have entered the 
researcher’s mind after gaining new insights leading to the discovery of new questions.  
My starting point came when I realised that my understanding of risk was somewhat 
lacking, if not outright naive. In the second half of the 1980s I was employed at the 
Norwegian Institute of Hospital Research (NIS), working with a reporting system for 
incidents involving medical devices in Norwegian hospitals. Such incidents had a few years 
earlier been identified as a major threat to hospitalised patients. My experiences from working 
with the incident reporting soon taught me that medical devices were not the largest iatrogenic 
risk to patients, after all (Skolbekken, Jystad & Elvemo, 1995). I also gained the important 
insight that the presentation of risk was not the mere presentation of facts, but also a result of 
actors’ selective presentation of the facts that suited their interests. This made me interested in 
the social construction of risk in health and health care, which has a central focus in this thesis. 
Eager to learn more about risk in modern medicine, the first aim of this work was  
• To study how risk is constructed in the medical literature.  
15 
 
This led to the discovery of the risk epidemic in medical literature, which is described in 
Paper I.  
The risk epidemic paper generated quite a few questions, some of which I have tried to 
answer in the other works included here. One of the conclusions about the risk epidemic was 
that it could be placed in a particular historical and cultural context. To better understand the 
history of this development thus became an aim, but the overall history was far beyond my 
ambitions and capabilities. For various reasons osteoporosis had come to my attention, and 
when asked to write a follow-up chapter to the risk epidemic in a Norwegian anthology 
(Swensen, 2000a), I included a literature search on the association between risk and 
osteoporosis. The outcome demonstrated how rarely articles about osteoporosis published in 
the 1960s and 1970s were articles about risk. By the end of the twentieth century, however, 
every third article about osteoporosis was also an article about risk (Skolbekken, 2000). 
Curious about what had happened in those few decades, the second aim of this thesis became 
• To trace the historical transformation of the medical understanding of osteoporosis in 
the latter half of the twentieth century 
My interest in the medical literature on risk also led me to regular visits to the library. 
Looking at the new issues of such journals as the BMJ and the New England Journal of 
Medicine in the late 1990s it was striking to notice what a prominent place risk reductions 
were given in advertisements for cholesterol reducing drugs. This eventually led me to write a 
paper about the risk communication in these advertisements (Skolbekken, 1998). About the 
same time there appeared a debate in Norway over the reimbursement of new drugs for 
osteoporosis, in what was called the ‘Fosamax-case’. This case caught my attention as it had 
obvious parallels to the issues I had covered in my risk communication paper. Furthermore, as 
Kristiansen (1998) commented that it was a fitting task for social scientists and historians to 
tell the “truth” about the case, it seemed a challenge worth pursuing when I shortly thereafter 
received an invitation to contribute to a Norwegian anthology. Without actually aiming for 
THE truth about the Fosamax-case it became my aim  
• To make a critical analysis of the Fosamax-case 
An issue regularly debated in the academic circles I frequent is the moral side of the present 
medical focus on risk. These debates tend to focus on the concern for possible negative effects 
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about the medical attention on risk. Anecdotal evidence, in particular from general practice, 
was frequently brought up in the discussions, but research based knowledge on the issue 
seemed to be lacking. To do research on what happens in healthy people lives when they are 
made aware of their own health risks thus became pertinent, and medical screening was found 
to be a most suitable area wherein this is done to whole populations. When the HUNT 
Research Centre were going to measure the bone mineral density of women in Nord-
Trøndelag, and tell them about their risk of osteoporosis, we were given an opportunity of 
studying how this affected these women’s lives.  
 The HUNT survey was comprised of bone mineral measurements and questionnaires 
about the women’s personal health status and history in relation to osteoporosis. This also 
meant that the survey provided an opportunity  
• To gain insight into women’s knowledge and beliefs about osteoporosis  
To make decisions about whether a person wants to know her risk status when she feels 
healthy can be challenging in many ways. Whether it is best to know or not to know a 
potential health problem is both an ethically and personally challenging question. For those 
feeling healthy, finding out that they are not  can be mind-blowing. To examine how the 
measurement of bone mineral density influenced the women of Nord-Trøndelag, we decided  
• To scrutinize some of the challenges faced by lay people in their interaction with 
disease categorization based on risk estimates 
All along my journey working with this project I had been grappling with reflections about 
whether there actually are any limits to the enterprise of modern medicine. Reading Williams 
and Calnan’s (1996) analysis of the ‘limits of medicalization’ made me realise that 
medicalization was not as straightforward as the first impression had lead me to believe. Still, 
as there seem to be few things that cannot qualify as a risk factor, I decided  
• To present a critical analysis of the close connection between risk calculation and 
medicalization 
As the reader will notice when getting to the papers that present the outcome of this research, 
the chronological order of their publication is not in a perfect match with the order of the aims 
stated above. There are several reasons for this discrepancy, the main one being a lack of 
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linearity in my reflections on these issues. Other contributions have come as a result of the 
timing of the different opportunities to do the research, and a third influential factor has been 
the variation in time between the writing of the different papers and their actual publication. 
The order of the papers is therefore admittedly constructed, with the purpose of presenting the 
reader with a comprehensive story of the subject under study. 
What observations a researcher makes and how he/she interpretes them depends on the 
position of the researcher. Before moving on to the theoretical perspectives that have guided 
my research, the reader will be informed about my position as a researcher, to better 
understand the choices that have framed this project. 
 
Position of the researcher 
As indicated above my research has been a journey spanning decades. My position as a 
researcher has thus developed along with the progress of my research. Pushed for an answer 
by one of our reviewers we claimed a critical realist position in one of the papers. With 
hindsight, and some regret, this is not entirely true. What is true, however, is that the 
statement reflects my blurred perception of an objective world and a socially constructed one, 
grappling with what Hacking (1999:14) has called the “difficult distinction between object 
and idea.” Rather than going into a discussion about essentialism here, I opt for the more 
pragmatic and simplistic reflections that have inspired my research. For a long time the words 
history and culture have made me reflect that things can be different. This has made me 
curious about the things we take for granted, and in particular things that are labelled as 
‘natural’. Realising that most things are not inevitably natural has spurred me to ask critical 
questions about the status quo, which can be seen as putting my work within the frame of 
social constructionism (Hacking, 1999).  
In the process of doing this research I have made the following statement about my 
position:  
behind this text lies both scepticism and doubt in solid proportions. My scepticism is related to an apparently 
unlimited medicalization of the population, wherein resources are reallocated from the sick to the healthy. My 
doubts are related to how central dilemmas in health policy are to be solved, and thereby doubts about what 
constitute the ‘right’ decisions. 
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This scepticism was not always there, as my training as a psychologist left me with a 
conviction that prevention is better than cure. As I came to realize that this first impression 
might have been deceiving, I started on the journey towards more critical positions that is still 
going on.   
My scepticism has influenced the issues that have become my subject of research. In 
this sense my research is ethically motivated, as an effort to contribute to the improvement of 
the human condition under investigation (Kvale, 1996). When performing the research, 
however, I have done my best to keep an open mind about the outcome, in a conscious strive 
to avoid drawing conclusions that go beyond my data.  
This is a position that I have held throughout this project, and it still remains my 
position. What has changed, however, is my understanding of my subject of study. This 
understanding has changed as the research has given me further insight into these interrelated 
topics. These factual clarifications have not changed my initial doubts about what the right 
decisions are. Rather than finding simple answers that enable me to draw clear conclusions, I 
have learned that matters are much more complex than what they seemed to me at first.  
Despite being critical about biomedicine I align with Roy Porter (1997) in his belief 
that it is the one current medical system that will remain dominant a hundred years from now. 
As indicated by my research question it is my position that our marriage to biomedicine will 
bring us good days and bad days. Rather than filing for a divorce, it is my belief that the most 
viable option is to work to improve the relationship. Summing up the above, it is my 
conclusion that my position is within reformist constructionism (Hacking, 1999). 
 In line with the description of the aims of my project I identify myself as a researcher 
close to what Kvale (1996) describes through the traveller metaphor. According to this 
metaphor the researcher is a person who goes on a journey before returning home to tell the 
tale of the conversations he has had with the people he has met on his journey. This concurs 
well with my personal experience of doing focus group research, which over the years has 
taken me to places and people I otherwise would not have met. Besides being a traveller, 
much of my research has also been performed in an armchair, reading and reflecting on the 
tales told by researchers that pursue the search for objective knowledge.  
 My position as a researcher has also influenced my choice of research tools. Without 
claiming that questionnaire-based research is without its virtues, I have a clear preference for 
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qualitative research. One of the reasons behind this inclination is my exposure to numerous 
questionnaires that asked me questions I sometimes found irrelevant and forced me to provide 
answers that were not really mine. To be able to learn from people that view things differently 
from myself, through various forms of qualitative research, has had far greater appeal to me 
than to be able to measure how thousands of other people respond to my limited edition of 
possible answers. A pivotal reason for doing research is discovering new things and hearing 
histories I have not heard before to gain genuinely new insights. Such insights will primarily 
be gained by asking open ended question and keeping an open mind to the answers, which I 
see as the main asset of qualitative research. 
My curiosity for learning about other people’s views has also led me to seek 
knowledge beyond my original academic discipline, psychology. Porter (1997) stated that the 
questions he posed regarding our present state (p. 7) may be questions fit for a psychologist to 
answer. I can thus claim to fulfil Porter’s requirement to perform this study, but the scope of 
psychology strikes me as too narrow for the pursuit of this work. As research is becoming 
increasingly complex, no single discipline will manage to provide all the answers. To be able 
to work within the frame of various cross-disciplinary research groups has thus enlightened 
me about what can be offered from such disciplines as sociology, philosophy and medicine. 
Add to that my personal conviction that we can always learn a lot from history, and we have 
the mix that has inspired this project.  
From the description of the aims of the study and my position as a researcher it is fair 
to conclude that this is not a project driven by theory. Although not driven by theory there are 
clearly theoretical perspectives that have guided the interpretation of my research stronger 
than others. It is to these perspectives we now move. 
 
Theoretical perspectives  
It has been observed that “risk looms large in present-day society” (Zinn, 2008a). As this 
thesis will show this is certainly true in medicine, whilst others have claimed that risk has 
come to define our present society (Beck, 1986). Judging from the rich variety of books and 
articles published on risk from various social science perspectives published in recent decades, 
there are ample theoretical perspectives to choose from. A complete review of the theoretical 
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literature on the social theories of risk is clearly outside the scope of this thesis. The interested 
reader will find a useful overview in Zinn (2008b). 
 When choosing my theoretical perspectives I have opted for those that I find having a 
scope that best embraces the scope of my empirical work. To be able to refer to such scholars 
as Beck, Douglas, Foucault, Giddens, Habermas, Luhmann, and Marx has been tempting. I 
have refrained from this as I see their work as having a much wider and less concrete scope 
than what is aimed for in this thesis. As my overall framework is within social 
constructionism I have opted for perspectives that have enlightened the social construction of 
health and illness, by applying various perspectives on medicalization, including that of 
scholars inspired by the work of Michel Foucault.  
 
The social construction of health and illness 
Ideas about health and illness vary across cultures and historical times. For the people living 
in a particular culture at a particular time these ideas are often taken for granted and as 
naturally given, whereas for a person from another culture or another time they may come 
across as strange, giving rise to a lot of questions. This situation is the basis on which the 
claim of health and illness as social constructions is built (Barber, 2010).  
As social constructionism come in many shapes, its introduction here calls for a clarification 
of my own perspective. Among the challenges posed by social constructionism is the degree 
of reality in the phenomena under study. My perspective on this matter generally agrees with 
that presented by Brown (1995), acknowledging the existence of objective problems that we 
as humans make social constructions about. In the context of this thesis this means that I 
consider what in medical and lay terms are constructed as heart attacks, strokes and 
osteoporotic fractures are indeed real problems to the people experiencing them. I also 
acknowledge that what we know as biomedicine provides the most effective treatment of 
these problems today, giving it a dominant position among medical systems. In choosing a 
social constructionist approach, it follows that this thesis is about ‘how illness is shaped by 
social interactions, shared cultural traditions, shifting frameworks of knowledge, and relations 
of power’ (Conrad & Barker, 2010:569). 
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 The core construction of this thesis is the medical concept of risk. As Ewald (1991) 
observed, anything can be a risk although nothing is a risk in itself. This point is also made by 
Heyman & Titterton (2010:11) who state that “In contrast to disease, pain, and death, risks 
never ‘exist’ independently of observers’ knowledge, beliefs and values.” A risk is 
furthermore a possibility of an unwanted event, but in many cases a risk also represents an 
event that will never happen. These statements illustrate very well some of the intellectual 
challenges that are posed by the concept of risk. 
 Before moving to a closer presentation of the medical concept of risk, it is useful to 
remind ourselves of the difference between the medical study of risk and the social science 
study of risk. Heyman & Titterton (2010) describes this as the distinction between the study 
of risk and the study of risks. Whereas risk in medicine is mainly studied with the purpose of 
reducing negative outcomes, the social science study of risk is focused on understanding risk 
thinking in society. Rather than managing risk, the social science study of risk focuses on the 
social processes that are involved in risk management (Alaszewski, 2006). In the presentation 
that follows I not only introduce theoretical concepts and perspectives, but also make an effort 
to place them in a historical context. This is done because I find this valuable for the 
understanding of the present situation. 
 
Risk in medicine 
Whether medicine has a ‘theory of risk’ is doubtful, but it most certainly has several concepts 
of risk. As such concepts are at the core of this study, I find it necessary to introduce it in this 
section. 
Risk in medicine is tied historically to the development of statistics and probability 
(Hacking, 1990). Its place in modern medicine is well established, albeit controversial. Life 
insurance companies were the first to make risk calculations based on medical information, 
with the purpose of preventing their own bankruptcy by not selling life insurance policies to 
high risk customers (Rothstein, 2003). 
Risk is a concept that reflects the complex causal relationships when epidemiologists 
seek to explain why various diseases occur. If the causation of a disease is monocausal and 
deterministic, it would be meaningless to talk about risk as the disease would then occur with 
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certainty. In medicine the belief in such monocausal models was held under what has been 
called the doctrine of specific aetiology (Rothstein, 2003). This doctrine was influenced by 
the 19th century identification of bacteria as a cause for infectious diseases, holding the 
presence of bacteria as a sufficient cause for such diseases. Although incorrect, it held for 
preventive purposes, as measures against the spreading of bacteria addressed a necessary 
cause of infections. A consequence of this is that preventive measures can be implemented 
despite imperfect knowledge about the causal mechanisms behind a disease. This 
imperfection has given a lot of room for negotiations around various public health policies, 
which has been eloquently described as the difference between sick individuals and sick 
populations (Rose, 1985). This insight gives rise to what has become known as the prevention 
paradox, implying that to achieve sickness prevention at the population level addressing 
people judged to have a low risk can be more effective than addressing those categorized as 
having a high risk.  
The statistical discovery of correlation at the turn of the twentieth century laid the 
ground for modern epidemiology, and the doctrine of multifactorial aetiology. It provided a 
way of pairing disease with any other measureable factor that came to be known as risk 
factors. It did not necessarily lead to the discovery of causality, but it provided a relation that 
served well for preventive purposes. Although both the technology for risk calculation and a 
technology for risk factor measurement (blood pressure measurement) was available from the 
early parts of the 20th century, it was not until the Framingham Heart Study half a century 
later that the concept of the risk factor was introduced to epidemiological research and public 
health medicine (Rothstein, 2003). Another factor introduced around the middle of the 
twentieth century was medicines that could lower blood pressure, thus reducing the risk factor. 
This medical treatment of risk factors made a whole new disease categorization possible 
(Greene, 2007). 
Throughout history there have been strong beliefs about associations between various 
behaviours and health outcomes, providing a strong link between morality and health. 
According to Brandt (1997) this linkage was broken with the introduction of germ theory and 
the belief in specific aetiology, which placed disease outside individual control. It was 
reintroduced, however, with the Framingham study which prepared the ground for the belief 
in the relation between individual behaviour and health. Basically this connection was 
established through the perceived control attributed to the knowledge about risk factors, 
23 
 
making it possible for individuals to choose their own fate. Such a belief can be contested in 
the light of social epidemiology, but for the purpose here it is important to note that this 
relationship made what has been called the medicalization of everyday life a distinct 
possibility. We will return to issue under the presentation of medicalization below.  
In modern epidemiology risk is defined as the probability that a person will develop a 
given disease (Rothman, 2002). Despite the eagerness to measure risk at the individual level, 
most medical risk calculations are based on studies of groups. The transformation of group-
based data into data meaningful at the individual level represents one of the major challenges 
when risk is communicated within various medical settings (Edwards & Prior, 1997). It also 
provides major challenges when public health policies are to be decided, research results are 
presented, or  a single individual is making choices about his/her own risk behaviour.  
Another complicating factor is the existence of several epidemiological risk concepts 
(Thelle, 2001). When the proportion of diseased in a population is calculated, the outcome can 
be described in terms of absolute risk. To know the absolute risk of one population has limited 
value if the ambition is either to understand the causality behind the disease or what measures 
that might help to prevent it. Epidemiologists have therefore developed several study designs 
for comparing the absolute risk in various populations. Doing so, they are able to calculate a 
relative risk, and thereby identify risk factors in the environment, life styles or bodies. 
 These concepts have further been developed in the discipline of clinical epidemiology, 
where risk reductions have become have important measurements of the efficacy of 
therapeutic and preventive measures in medicine. Such outcomes can be stated both in terms 
of absolute and relative risk reductions, and the concept of number needed to treat has also 
been introduced as a concept in the measurement of the efficacy of medical interventions. 
Clinical epidemiology can thus be seen as providing the tools that, paired with the ideological 
reflections of Archie Cochrane (1972), prepared the ground for the introduction of evidence 
based medicine (EBM) (Sackett, Richardson, Rosenberg & Haynes, 1997). 
 One of the consequences of the medical understanding of risk is that everybody can be 
seen as potentially sick, as we are all at risk of something (Armstrong, 1995). This knowledge 
has opened for new social identities as ‘being at risk’(Novas & Rose, 2000), which implies 
that the person feels well, experience no symptoms, but has an awareness that the potential for 
becoming sick is always there (Scott, et al. 2005). Diagnostic uncertainty as the outcome of 
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medical surveillance can also be seen as leading to a status as ‘patient-in-waiting’, leading to 
extended medical attention over time as uncertainty prevails as to whether the person’s test 
results are to be perceived as normal or pathological (Timmermanns & Buchbinder, 2010). As 
medical treatment of ‘at risk’ conditions have become more frequent, a convergence between 
the experience of risk and disease has also been described. This has led to profound 
transformations in the lives of both the chronically diseased as well as those identified as 
being at risk. Among these are the constant and lifelong medication, continued screening and 
lifestyle modification. For the individual this development can represent a disturbance to  
peace of mind, whereas for society it carries substantial economic costs and carries the 
potential of making distractions from other health goals (Aronowitz, 2009).  
 It can thus be argued that the medical notion of risk has played an important role in 
making things that have historically been outside the realm of medicine become legitimate 
targets for medical interventions. Such transformations can be seen as examples of 
medicalization, which literally means “to make medical” (Conrad, 1992). To better 
understand what this implies we now turn to the literature on medicalization, keeping in mind 
that medicalization is another social construction. 
 
Medicalization 
Just like risk, medicalization has become one of those terms that has been integrated into our 
everyday language. In Norway the term is commonly expressed as ‘sykeliggjøring’, indicating 
the ability to define something or someone as sick. This coincides well with what can be seen 
as the classic way of defining medicalization in the professional literature. Medicalization has 
also for a long time been associated with something negative. As we shall see this is an 
association that is now being challenged.  
The study of medicalization has been one of the central subjects in the sociology of 
health and illness since the late 1960s. It is worth noting, however, that the idea of 
medicalization has existed long before it caught the attention of social scientists. This point is 
vividly illustrated by this quotation from an interview with Søren Rognstad on his 90th 
birthday in 1916:  
“Have you never been sick? 
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No, says the old timer. We didn’t know anything about sickness in the old days, as we didn’t have any 
doctors or medicines or such things. And then, you know, people stayed healthy.” (Indlandsposten, 
1916). (My translation). 
To date medicalization itself depends on how we define it. If medical doctors are seen as the 
only prerequisite for medicalization, it can be argued that it has been around as long as 
medicine, which in the Western world is traced back to antiquity and Greece (Porter, 1997). 
Another historical tracing of the concept indicates that medicalization has been around for the 
past couple of centuries, arising with the development of public health in the new national 
states (Nye, 2003). This correlates well with the observation that the idea of periodical 
medical examinations of healthy people has been dated back to 1861 (Han, 1997).  
Others have traced medicalization to more modern times, related to the formation of 
the profession of medicine as we know it in the 20th century (Freidson, 1970; Collyer, 2010). 
Similar claims have been made by Conrad & Schneider (1992) who describes medicalization 
as a process reflecting the rising power of the medical profession, through the transformation 
of various forms of social deviance into medical diagnoses. In her recent description of the 
development of medicine Clarke (2010) describes the period from 1890 to 1945 as the rise of 
medicine, and medicalization as starting as late as after World War II, only to be replaced by 
biomedicalization around 1985.  
 In his most recent book on medicalization Conrad (2007) has defined it as a process 
wherein a nonmedical problem is transformed into a medical one. This definition is intended 
to be descriptive and aim to depict medicalization as a neutral term. Neutral as the definition 
may be, medicalization is very much a contested process, illustrated by what has been called 
the medicalization critique. A central tenet of this critique is that medicalization puts an 
individual in an undesired state of being, which should be resisted (Lupton, 1997). Another 
important part of the medicalization critique was the distinction between legitimate and 
illegitimate domains of medicine, seeing medicalization as illegitimate extensions of medical 
realm (Davis, 2006). Such extensions  also at times appear under the name of 
overmedicalization (Conrad, 1992). 
This conceptualization points to some kind of medical essence, indicating that 
something medical exists beyond the social construction of it. Conrad (2007) can be seen as 
doing the same when stating that it is beyond his expertise to assess what is really a medical 
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problem, as he indicates that somebody else may have that capacity. In one of his latest 
contributions to the medicalization literature Conrad (and co-workers) can be interpreted as 
having this capacity after all, as they make a distinction between medicalized and non-
medicalized conditions in an effort to estimate the costs of medicalization (Conrad, Mackie & 
Mehrotra, 2010). Their own observation that their exercise may lead to discussion about the 
inappropriateness of medicalization underlines this. These examples illustrate two points; the 
challenge of holding a consistent social constructionist position, and the difficulty of being 
neutral about medicalization. In an effort to get around the question of medical essentialism 
Sadler, et al. (2009) have replaced ‘nonmedical problems’ with ‘human problems’ in 
Conrad’s definition, thus defining medicalization as ‘a process by which human problems 
come to be defined as medical problems.’ (p. 412). In an even more pragmatic approach 
Clarke (2010) has offered the term ‘things medical’, indicating that it is what people construct 
as being medical that belongs there. Such notions of medicalization opens the possibility that 
medicalization can happen without the presence of doctors. As such this notion of 
medicalization challenges what for a long time has been the accepted conceptualization of it. 
Despite this, I find it appealing as it reflects the complexity of recent developments, refuting 
the depiction of medicalization as a tool reserved for doctors.  
 
The medicalization critique  
Among the classical contributors to the medicalization critique were such scholars as Freidson 
(1970), Zola (1972) and Illich (1976). Through terms such as medical imperialism and 
professional dominance they placed the medical profession in a cardinal position. Zola (1972) 
described medicine as replacing law and religion to become the major institution of social 
control in society. Illich (1976) defined the outcome of the professional dominance of 
medicine as a form of iatrogenesis, sickness inflicted by doctors leading to the medicalization 
of life. By doing so, doctors were depriving people of their ability to take care of their own 
health, rendering them dependent on the medical profession.  
Among the negative outcomes of medicalization were its detrimental effects on 
women, through the reinterpretation of what had previously been seen as natural bodily 
processes into medical conditions. Although fostering a strong feminist criticism, it has also 
been concluded that the early sociological criticism of medicine overstated the medical 
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imperialism argument, whilst at the same time downplaying the benefits of medical 
interventions (Ballard & Elston, 2005). The medicalization process was also depicted as much 
more complex than what the original theories portrayed it as (Fox, 1977). Historically, the 
medicalization of women could also be seen as the outcome of interactions between doctors 
and women within particular historical contexts (Riessman, 1993). This illustrated how 
women were not merely passive victims of medicalization, but active co-constructors of it, 
and that this was particularly true for middle-class women.  
In recent decades the medicalization critique has also been supplemented by texts 
taking a more positive angle on medicalization. Whereas it for a long time has been subject to 
feminist criticism, demands for more medicalization under a feminist ethos have now been 
aired. Rather than condemning medicalization altogether, the critique is aimed at what is seen 
as undesirable medicalization (Purdy, 2001).  
We have thus far noted two notions complicating the construction of medicalization - 
that it can happen with and without doctors, and that it can be both positive and negative. As 
we shall see, the simultaneous appearance of limitations and expansions makes it even more 
complicated. Before we go there we also need to look at the medicalization of everyday life, 
which has been viewed somewhat differently within the medicalization literature. 
 
The medicalization of everyday life 
The connection between risk and medicalization is to a large extent related to the 
medicalization of everyday life. This connection was observed already by Zola (1972) in his 
seminal paper. To see health as the outcome of human behaviour was not a new idea, as this 
connection had been established through the religious construction of sin (Rosenberg, 1997). 
What was new was the secularized notion about behaviours, wherein scientific observations 
of risk became a part of the moral reasoning about health and behaviour. This placed the 
medical profession in a central position for social control. 
 Noticing that concerns about health had become a national preoccupation for the 
middle classes in the USA, Crawford (1980) introduced the concept healthism as the ideology 
making personal health a primary focus for well-being. Such well-being was achieved through 
certain life styles associated with good health, based on the assumption of individual 
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responsibility for health. This can be seen as one of the first observations where not only 
sickness, but also health were seen as being subject to medicalization. 
 One interpretation of healthism is that it can be seen as an effort by ordinary people to 
regain control of their health, as a countermeasure to what Illich (1976) called social 
iatrogenesis. Such an interpretation could furthermore lead to seeing healthism as a form of 
demedicalization, a description that also was offered by other scholars in the 1970s (Fox, 
1977). A different interpretation was offered by Conrad (1992), however, when he argued that 
risks for what he called well-established medical conditions did not belong under his 
definition of medicalization. Instead he suggested that this should be called healthicization. 
This is as position he has since renounced, and he  currently places risk and surveillance 
among the themes of medicalization (Conrad, 2007). 
 Whether a healthy lifestyle can be traced to medical dominance or is seen as the 
healthy choice of the well informed consumer, both represent a form of medicalization 
(Lupton, 1997). The defining factor is whether a person performs an act with the purpose of 
promoting health or preventing disease, not whether the idea came from a doctor or some 
other source of information on health matters. This concurs with my position on the 
medicalization of everyday life. 
 
Limitations, extensions and expansions 
Medicalization is rarely seen as complete and only a few conditions are seen as fully 
medicalized. No formal categorization or analysis has been performed on this subject, but 
Conrad (1992) has implied at least three degrees of medicalization (minimally, partly and 
fully). Competing definitions of a problem, availability of treatments, support of the medical 
profession and acceptance among the people affected by medicalization are among the factors 
influencing to what extent medicalization can be seen as complete or not.  
Another conceptual issue is related to its limitations. Whereas the early notions of 
medicalization took the professional domination of patients for granted, later theorists have 
claimed that there are several developments in modern society that represent limits to 
medicalization. (Williams & Calnan, 1996). As a consequence medicalization is portrayed as 
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a process that will be subject to the lay population’s reflections, challenging the authority of 
the medical profession. 
Reflexivity among doctors can contribute to the limitations to medicalization. This is 
illustrated by what happens when patients experience symptoms, but doctors are reluctant to 
make a diagnosis, like in the case of chronic fatigue syndrome (CFS) which has been 
described as a situation leading to incomplete medicalization (Broom & Woodward, 1996). It 
has further been argued that this was a situation where medicalization should be mobilized in 
collaboration between doctors and patients, but with the avoidance of the involvement of 
medical dominance. 
The ultimate form of limits to medicalization can be seen as happening through the 
process of demedicalization. This occurs when a problem is no longer defined in medical 
terms and is no longer subject to medical treatment. Demedicalization is extremely rare, 
however, and Conrad (2007) mentions masturbation and homosexuality as the most 
prominent examples. Medicalization is thus a difficult process to turn around once it has been 
established. Despite resistance from various groups in society, the general picture is one of an 
ever expanding medicalization.  
Conrad (2007) thus also describes medicalization as going through extensions and 
expansions. The medicalization of male aging, through the construction of the andropause, 
baldness and erectile dysfunction are presented as examples of the former. Typically these are 
conditions that are established through interactions between aging men, their doctors and the 
pharmaceutical industry. Expansions may come in the form of diagnoses expanded to new 
categories of people, as when hyperactivity among children became an adult diagnosis. This is 
also shown when an effective treatment is expanded to wider groups of people through the 
design of diagnostic tests that lead to an expansion of the diagnostic category, as has been the 
case with serotonin reuptake inhibitors (SSRI) and depression.  
 
Pharmaceuticalization 
Parts of these expansions are clearly related to what has been called the shifting engines of 
medicalization. Through this shift the medical profession has lost its central place in 
medicalization to the pharmaceutical and biotechnology industry (Conrad, 2005), and the 
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perceived transformation of patients into consumers have provided a marketplace where 
doctors play a mediating role between other actors (Conrad & Leiter, 2004). This is seen as 
particularly true in the USA where direct-to-consumer advertising is allowed for prescription 
drugs. 
 Busfield (2006) stresses the importance of studying the production of scientific facts 
about drugs, and also talks about the importance of the drug companies’ ways of proving the 
effectiveness of their products. Based on the global expansion in the use of medicines in 
recent decades, it has been concluded that prescribing medicines have become the dominant 
form of health care, in particular in high- and middle-income countries (Busfield, 2010). 
Cholesterol reducing drugs are furthermore among the best selling drugs world-wide, 
illustrating the impact of drugs with risk reducing qualities. 
Some sociologists have also taken this analysis one step further by introducing the 
concept ‘pharmaceuticalization’, which Abraham (2010:604) has defined as ‘the process by 
which social, behavioural or bodily conditions are treated or deemed to be in need of 
treatment with medical drugs by doctors or patients.’ What makes pharmaceuticalization 
different from medicalization is that the former is the process that takes place when other 
ways of treating an already defined medical condition are replaced by drug treatment. In the 
case of risk factors this is what happens when life style interventions are replaced by 
chemoprevention. Where medicalization and pharmaceuticalization are seen as mutually 
reinforcing, as with health risks, Abraham (2010) talk about the ‘medicalization-
pharmaceuticalization complex’. The development of hypertension as a disease can be 
explained in this way, as illustrated by the half a century that passed from the availability of 
blood pressure measurements to the definition of it as a disease in its own right that appeared 
after the introduction of thiazides (Greene, 2007). 
 In an effort to describe a sociological program for the study of pharmaceuticalization, 
Williams, Martin & Gabe (2011) have identified several key dimensions for its sociological 
analysis. Although not being able to claim that their suggestions have inspired the work on the 
papers included in this study, several of the studies included in this thesis can be claimed to be 
in accordance with their suggestions.  
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Governmentality 
Whereas the medicalization critique focused on medical power as a tool for repression of the 
population, an alternative interpretation of medical power has been inspired by Michel 
Foucault’s writings. In these interpretations medical power is seen as being used for the 
benefit of the population, by persuading them to believe that their health will benefit from 
certain ways of thinking and behaving. Although never labelled as medicalization by Foucault, 
it has been interpreted as offering an alternative perspective on medical power (Lupton, 1997). 
The theoretical framework on risk which has been applied in this work is the Foucault-
inspired work on governmentality (Dean, 1999a). This concept is based on the combination of 
‘government’ and ‘mentality’. Government is further described as the ‘conduct of conduct’, 
which in modern society is achieved through the governments’ ability to influence the 
mentality of its citizens. Among the goals of government is the health and well-being of its 
citizens, which is believed to be achieved by a certain conduct from the citizens. By 
convincing the citizens that abiding to such conduct is both moral and rational, the 
government is exercising its power. Risk thus becomes a tool in this exercise of power, 
through what is described as a calculative rationality (Dean, 1999b). In the context of health 
and illness this power is exerted with the aim of keeping the population as healthy as possible. 
 In this theorizing, risk is described as a social construction, as it is seen as not existing 
in reality. In its calculable form it is a number which gives significance to whatever it gets 
attached to (Dean, 1999b). Such attachments can be made through epidemiological 
calculations, identifying risk factors. What has been called the discourse of risk has been 
described as being central to public health practices in contemporary societies. The dominant 
theme of this discourse is the individual’s responsibility to avoid health risks, which can also 
include such practises as undergoing risk assessments like various forms of screening (Lupton, 
1995). In what has been called “the new public health” risk knowledge based on 
epidemiological studies provides the basis for guiding individual behaviour (Petersen & 
Lupton, 1996). 
 The perhaps most ardent critique of the medicalization concept has come from within 
the ranks of scholars standing on Foucault’s shoulders. Nikolas Rose has claimed that 
medicalization has become a cliché. Rather than using the concept as a starting point for 
critical social analysis, he claims that medicalization has made us what we are (Rose, 2007a). 
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This is a position he has deepened in his analysis of the politics of life itself, wherein he 
claims that medicine plays an important role in this politics, which has largely been to the 
benefit of humans (Rose, 2007b). 
 The latest theoretical contribution to the literature on medicalization is somewhat 
harder to place. As it in part is based on the ideas of governmentality, and in particular the 
work of Rose, I choose to put in under this heading. Acknowledging the rising complexity in 
medicalization Clarke, et al. (2003/2010) argue that it has now reached an entirely new stage 
which they have named biomedicalization. The process of risk and surveillance can be seen as 
particularly salient in these developments. Where medicalization has focused on control over 
medical phenomena, biomedicalization is said to study the transformation of the same 
phenomena. It is thus claimed to cover nothing less than the technoscientific transformations 
of health, illness and US biomedicine. Its scope and ambition goes far beyond the work 
presented in this thesis, but it is still included here as a reminder of the complex theorizing 
that is currently framing the area of medicalization. 
 
Osteoporosis 
Major parts of this thesis are related to osteoporosis. For readers unfamiliar with this 
condition I find it appropriate to give a short description of the medical construction of it. In 
brief, the medical discourse on osteoporosis is summed up quite aptly in this message from a 
publisher promoting a book doctors are urged to read: 
‘Osteoporosis is a devastating disorder with significant physical and psychosocial consequences. One in 
three women and one in 12 men over the age of 50 in the UK already suffer from osteoporosis, and 
every three minutes it is estimated that someone has a fracture due to this disease. However, due to the 
remarkable progress in the scientific understanding of its causes, diagnosis, and treatment, this disease 
is now largely preventable.’ 
(Researchandmarkets) 
Whether this optimism is substantiated or not is open for debate, but the core message of 
‘there is plenty of reason to worry, but help is at hand’ catches the modern medical ethos quite 
well. We will proceed with a more sober description, however. 
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In medical terms osteoporosis has a natural history related to a lifelong process of 
continued renewal of the mineral structure of the bone (Ballard & Purdie, 1996). It is when 
this process is disturbed that osteoporosis and eventual fractures will occur. To achieve the 
highest possible peak bone mass is believed to be the most important way of preventing 
osteoporosis. This is achieved early in life through dietary measures and exercise, in addition 
to avoiding such risk factors as smoking and alcohol abuse. The attainment of peak bone mass 
is followed by an age-related loss in bone mass. When women are more frequently affected 
by osteoporosis than men this is related to the higher peak bone mass achieved in men, and 
oestrogen’s effect on the bone resorption/formation balance. Lack of oestrogen is thus 
depicted as having a major impact on the bone rebuilding process in women, although how 
this ‘deficiency’ affects men is poorly described in the medical literature.  
In a frequently cited article, Cooper, Campion & Melton III (1992) have made a 
projection for osteoporosis portraying it as a world-wide health problem in the years to come. 
Their projection is based on population data and hip fracture incidence rates from various 
regions of the world. Whereas osteoporosis in the late 20th century was a disease affecting 
people in high income countries of the western world, this is believed to change drastically 
towards the middle of the 21st century. This is mainly related to demographic changes that 
indicate that by 2050 three quarters of all elderly people will be residents of Asia, Latin 
America and Africa. About 70 % of the fractures were believed to affect women, as 4.47 
million women were projected to experience hip fractures in 2050. Although the authors see 
limitations to their projection, due to varying quality of available epidemiological data, they 
still believe their numbers to represent an underestimate of the incidence rates for low income 
countries. I do not make any assessment of the validity of the presented numbers, but take its 
frequent citation as an indication that it is against the background of these projections that the 
present preoccupation with osteoporosis and its prevention should be understood. 
At the individual level osteoporotic fractures are characterised as painful, having 
disabling effects, and have also been described as contributing to excess mortality (Haentjes, 
et al. 2010). The present interest in the prevention of fractures can thus be seen against the 
background of a globally escalating health problem causing great suffering in the affected 
individuals. Much of this interest is related to the construction of osteoporosis as a risk factor 
for low impact fractures, and it is this notion of osteoporosis that we will be attended to in 
major parts of this thesis. Central to this understanding of osteoporosis is the WHO-definition, 
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which contains the classifications normal bone density, osteopenia and osteoporosis in 
addition to osteoporotic fractures (Kanis, et al. 1994). These categorizations are based on the 
normal distribution of bone mineral density in the population and risk assessments made by 
the medical expertise. 
A prime example of the current medical interest in osteoporosis is the development of 
the Fracture Risk Assessment Tool (FRAX®) (Kanis, et al. 2010). As indicated by the name 
this is a tool which has been developed to identify individuals in need of treatment for 
osteoporosis, based on the presumption that effective treatment is now available. Whereas 
bone mineral density (BMD) has been the centre of attention in calculations of the risk of 
osteoporosis for some time, the 10 year fracture probability that is calculated in FRAX also 
takes into consideration a series of other risk factors. A somewhat unique feature of this risk 
calculation tool is also that it has been constructed to embrace the global variation in fracture 
risk.  
A primary aim of the application of FRAX® is to identify people that are believed to 
benefit from drug treatment. This drug treatment is at present primarily provided in the form 
of bisphosphonates, which in randomized controlled trials have been shown to reduce the 
fracture risk among people with previous vertebral fractures, although the evidence about 
what can be achieved in people with osteopenia but without prior fractures is characterized as 
inconclusive (Eastell, et al. 2011). 
 This concludes the introductory part of the thesis. We will now proceed with the 
presentation of the methodology applied to reach the aims of this study.  
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METHODS AND MATERIAL 
The diversity of the aims in this project has demanded the application of several research 
methods. Each method has been selected because it was believed to fit the purpose of its 
respective sub-study. My data are thus based on various sources such as literature data bases, 
academic texts, newspaper articles and interview transcriptions. Overall the study is 
qualitative in design, although it can be argued that the first sub-study clearly has a 
quantitative element. It would be possible to claim that this study contains elements of both 
methodological and data triangulation (Flick, 2007).  
 
Literature study 
The literature study that led to the identification of the risk epidemic in medical journals 
started off in an explorative fashion, as the findings simultaneously clarified the answers to 
some questions as well as generating new ones. Observing what looked like a trend led to a 
more systematic study of the publication rates in five year intervals. The chosen intervals may 
seem arbitrary in our accustomed thinking about decades, but the starting point was simply 
taken from the first year  MEDLINE was available at the library (of the Norwegian Institute 
of Hospital Research).  
 The first sampling decision was to look for articles with the word risk(s) in title and/or 
abstract of the articles. This choice was based on the belief that if risk appeared there it could 
be considered as a significant theme in the article. These articles were then characterized as 
‘risk articles’. 
 As the trend appeared the question arose as to whether this was merely a reflection of 
a general increase in the total number of articles published. To check this out the total number 
of articles published for the same periods as the risk articles were found. Then the percentage 
of risk articles was calculated, demonstrating that the percentage of such articles in 
MEDLINE increased in every five year period. Having done this, this search was repeated for 
several subsamples of journals. These subsamples covered some of the most prestigious and 
well read generalist medical journals in the world, as well as similar Scandinavian journals. 
 Another question that arose from the dialogue with other researchers around my 
findings was the question on whether the risk epidemic could be seen as the outcome of a 
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change in the academic vocabulary. To check this out the search procedure was repeated with 
the terms ‘hazard(s), ‘danger(s)’ and ‘uncertainty(ies)’ replacing ‘risk(s)’.  
In addition other journals from the same countries were selected, mainly medical sub-
specialities that were considered to be ‘risk prone’, as anaesthesiology, and obstetrics and 
gynaecology. A couple of epidemiology journals were also added, as risk was seen as a 
particularly important concept in that field. 
 
History study 
Paper II is based on a selected reading of the medical literature through a strategic sampling 
of articles and other medical publications. As with other qualitative studies we tried to 
identify key informers in the form of medical publications that contained the most important 
information about the various medical definitions of osteoporosis. Starting with literature 
searches containing the terms ‘osteoporosis’ and ‘definition’ in the ISI Web of science 
database, we identified a first set of articles. From these articles we checked both the citations 
made in those articles, as well as articles citing them. Through this process we also came 
across other documents, of which reports from consensus conferences proved particularly 
useful. 
 Before starting the study we had identified the publication of the 1994 WHO 
definition as the endpoint for our study. We also sent a letter to the WHO asking for access to 
their archives, to be able to trace whatever documents they might have from the work of their 
expert group. Unfortunately, we never received any reply. In the early phases of our sampling 
we identified Albright’s work as the foundation for what can be called the modern medical 
understanding of osteoporosis. This helped us narrow the study to the time period from 1940 
to 1994. From there on the work became more analytical in an effort to understand the 
historical development of the medical conception of osteoporosis. This was done by 
identifying the different forms of osteoporosis that were described in the literature and 
analysing the basis for these different conceptions of osteoporosis. 
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Media study 
This can be described as a case study based on the articles that the newspaper Aftenposten 
printed in 1996 and 1997 covering what was then known as the Fosamax-case. By using the 
search engine provided on the newspaper’s website using the Norwegian words for 
osteoporosis (benskjørhet), drugs (legemidler), and Fosamax. This material was sampled 
through purposeful sampling, as this newspaper’s coverage of the case was found to be the 
most comprehensive coverage of it. After identifying the articles on the internet, they were 
also found on michrofisch, so that the analysis could be based on the original print versions of 
the articles. Attempts to access more tabloid descriptions of the case were also made from 
Dagbladet and Verdens Gang, with a meagre outcome. The Aftenposten articles were then 
subject to a content analysis resulting in a narrative about the Fosamax-case.  
 
Focus group study 
The focus groups study that is the base for papers IV and V was designed as a prospective 
study, acknowledging the value of doing a study that would cover the women’s reflections 
before, just after and some time after having the bone scan. This design was also based on 
descriptions of designs used when women’s reactions to undergoing mammography had been 
studied (Swanson, McIntosh, Power & Dobson, 1996). 
 Focus groups were chosen as a method for both practical and principal reasons. The 
practicality was related to the fact that the interviews had to be performed in a different 
county than we as researchers live in. Locations for the focus groups were therefore chosen 
within a range of places being no more than two hours travel from Trondheim. Another very 
decisive factor on our choice of locations was the sites that HUNT Research Centre had 
picked for their screening. Among those locations we chose the towns, simply to avoid 
recruiting too many women that had made acquaintance before meeting with their group.  
 With the travelling distance that had to be covered semi-structured interviews with 
separate individuals was no real option, as that clearly would be outside both our time- and 
financial budget. The design was further influenced by our preconception that osteoporosis is 
an issue that may have a different significance to women at different times in their lives. 
Subsequently we decided to perform the study among different age groups. Our knowledge of 
the sampling for the HUNT screening also made us go for a further stratification in our 
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sample, selecting groups of women that had or had not experienced a bone scan before. 
Following Krueger’s (1994) prescription that a focus group study should consist of at least 
three groups, our stratifications led us to three categories of women. With three groups for 
each category the total amount of groups became nine, and each group met three times.  
 In some places we were allowed to use the same locations as HUNT Research Centre 
used for their survey, whereas in others we used public buildings well known to our 
participants. We made sure that the sites of our focus groups could be reached by public 
transportation, as we anticipated that our eldest participants belonged to a generation of 
women who had not acquired a driving licence. In line with local tradition of hospitality we 
served refreshments during the group sessions.  
 The focus group discussions were done in the mode of a semi-structured interview, 
based on a structure of five core questions, which were followed up by the moderator 
depending on the topics the women brought into the conversation. We had allocated two 
hours for the group sessions, leaving around 25 minutes for each topic. All the questions had 
been printed out and copied, and were handed out to the participants. This made it possible for 
the women to see the questions, not only hear them. This gave us the possibility of posing 
somewhat longer questions than what is normally viable when the questions are asked 
verbally, which we saw as an advantage. Another advantage was that the moderator could 
lead the women’s attention back to the paper in front of them whenever he felt that the 
conversation was getting too far off topic. To avoid women turning to the next question 
before being finished with the present topic of discussion, we passed the question one at the 
time rather than handing out the complete set at the beginning of the discussion. Before the 
start of each discussion we gave the women a briefing about what was expected from them, 
stressing that there were no right or wrong answers to our questions, but that their honest 
answers were the best data we could hope for. In addition we also asked them to make an 
effort to talk one at the time, not only because it would be considered polite, but because it 
would make the transcribing of the discussions much easier. 
 All group sessions were audiotaped on two cassette players. The double recording was 
done in an effort to have a back-up in case of equipment failure and the possibility of getting 
clear recordings from various positions around the table. We were always three people in the 
research team – a moderator, a co-moderator, and a person taking notes for identification 
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purposes. As we recorded the sound only, this last job was introduced to record who was 
talking. This was done by writing down the three first words uttered by the woman presently 
talking. Albeit not an easy task when the participants got warmed up, this procedure gave a 
good start to our subsequent transcriptions. 
 In the group sessions it was quite evident that we as researchers were seen as experts, 
leading the women to talk to the moderator and not to each other in the beginning of the first 
group meeting. Another common feature of the first meetings was that the women had quite a 
few questions about osteoporosis which they hoped to get an answer to. This became most 
evident at the very first group meeting, where the co-moderator (SF) had introduced herself as 
a medical doctor and epidemiologist specialising on osteoporosis research. As a consequence 
any question the women had that night was passed with a look in her direction, hoping for the 
expert’s answer. As our purpose was to get access to the lay opinions and experiences this 
became a situation we had to deal with. In the rest of the study we did this by SF presenting 
herself as a researcher, without giving further information about her field of expertise. 
Furthermore, the moderator consequently returned any question directed at him to the group 
for further discussion. To calm the women’s interest in getting expert answers we also made 
the deal with them that we would provide an expert to give a talk about osteoporosis for them 
at the end of the final group meeting. By doing this we believe that we created a win-win 
situation by meeting the participants’ craving for information, whilst at the same time 
motivating them to turn up for a third meeting almost six months after the first two meetings.  
 Data analysis was performed in accordance with procedures described by Kvale 
(1996). For Paper IV we divided the material between us after reassuring that we had 
developed a common and reliable coding practice. For Paper V the data analysis was initially 
performed by one member of the team (JAS), and the data analysis was thereafter checked 
and discussed with the co-authors as a form of reliability-check. 
 Ethical approval for the project was given by the Regional Committee for Medical 
Research Ethics (REK) (Appendix). The participants were recruited by means of a personal 
letter (Appendix), sent by the HUNT Research Centre. This procedure ensured that we did not 
know the identity of our participants until they themselves replied to our query. Upon arriving 
at the location for the focus groups the women gave their written consent. In addition to 
giving their written consent they were also asked to sign a declaration of confidentiality 
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(Appendix). This was done in an effort to ensure that the women’s confidentiality was 
ensured not only by the researchers, but also among the group members. 
 
Critical reflection chapter 
This paper does not contain any empirical data of its own. Rather it is based on a critical 
reading of the literature that concerns the development of medical guidelines based on risk 
factor epidemiology. As mentioned in the presentation of the aims it was originally spurred by 
my reading of Williams & Calnan’s (1996) article on possible limits of medicalization, and 
also influenced by matters discussed within the Bioethics Research Group at NTNU. 
A first version was presented and discussed at an international conference, and was among the 
presentations from the conference chosen to be published in an anthology. 
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FINDINGS 
Paper I  
Skolbekken J-A. (1995). The Risk Epidemic in Medical Journals. Social Science & Medicine, 
40, 291-305. 
 
Reflections on the prominent place of risk in thoughts about health and health care in the late 
20th century triggered an interest in studying the risk concept in medical literature. The aim of 
this paper was to get a better understanding of the mechanisms leading to this observation, 
seen as an outcome of the social construction of risk in health and health care. This improved 
understanding came in the form of a description of trends in the occurrence of the term risk in 
the medical literature and the suggestion of hypotheses on the causes behind these trends. 
Covering the period from 1967 to 1991 the overall finding was that the frequency of risk 
articles (articles containing the word risk(s) in the title and/or abstract) had risen from 0.1 per 
cent in the late 1960s to around five per cent of the articles published in Medline in the early 
1990s. A significant finding was that more than half of the then published risk articles had 
been published from 1987 to 1991.  
 Further analyses were performed on several subsets of journals from the UK, USA and 
Scandinavia. The overall trend was replicated in most of the subsets, to the extent that the 
trend was shown to be even stronger in the majority of the subsets. The general medical 
journals and journals in obstetrics and gynaecology peaked at 12 and 19 per cent, respectively. 
Although the American journals peaked higher than the rest, the overall trend was the same in 
all three geographical areas that were studied. 
The overall trend was not replicated in journals covering anaesthesiology, though. 
This finding could be due to a lack of epidemiologically based articles in these journals. Such 
articles can be seen as taking a more prominent place in the other subsets of journals that were 
studied. The prominence of risk in epidemiology was further underscored by data from two 
epidemiology journals where risk articles constituted around half the published articles in the 
last five year period covered by the study. A manual analysis on the subset of articles from the 
Journal of the Norwegian Medical Association showed that the number of risk articles 
covering iatrogenic risk was by far outnumbered by articles on risks without iatrogenic origin.  
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One possible explanation behind what was now described as a risk epidemic could be 
a change in terminology. To look closer at this possibility further analysis were performed 
including the terms hazard(s), danger(s) and uncertainty(ies). The trend found in association 
with risk was not replicated for these other terms, underscoring the trend as unique for risk.  
As the original article was published 16 years ago, it is fair to ask if its findings are 
still valid. The answer to this question is a very strong yes. Two minor updates have been 
published since, both showing that the risk epidemic is still rising (Skolbekken, 2000; 2010). 
The trend proved to be strongest in the last period studied, as noted in the original publication. 
This is still true today, making the developments in the last decade most interesting. As can be 
seen from Table 1, the number of risk articles published so far in the 21st century outnumbers 
the total number published before that decade; at any prior time in history. 
Table 1. The risk epidemic in the 21st century.1 
YEAR RISK ARTICLES PUBLICATIONS % RISK ARTICLES 
2001 36 397 543 250 6.7 
2002 39 357 560 434 7.0 
2003 43 962 590 783 7,4 
2004 48 491 635 180 7.6 
2005 56 183 695 760 8.1 
2006 62 160 741 376 8.4 
2007 67 808 779 022 8.7 
2008 75 326 827 541 9.1 
2009 81 015 865 219 9.4 
2010 89 835 923 711 9.7 
TOTAL 600 534 7 162 276 8.4 
 
 
                                                            
1 Based on a search performed in Pubmed on 2011-11-14. 
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Paper II  
Santora, L. & Skolbekken, J-A. (2011). From brittle bones to standard deviations – the historical 
development of osteoporosis in the late 20th century. Science Technology & Human Values, 36, 497-
521. 
 
Osteoporosis is at present described as a major global public health problem, which has been 
predicted to become a catastrophic epidemic by the year 2050. In modern medicine it is 
understood as a skeletal disorder leading to increased risk of bone fractures at various skeletal 
sites in the body. The present definition of osteoporosis is clearly related to medical risk 
assessments, which represents a rather new approach to the medical understanding and 
definition of osteoporosis. Our aim for this article was to trace the historical transformation of 
the medical understanding of osteoporosis in the latter half of the twentieth century. 
Although osteoporotic fractures have a long history in medicine, we took Fuller 
Albright’s work around 1940 as our starting point. His studies can be seen as the first 
scientific study of osteoporosis, through the identification of its relation to oestrogen. This 
discovery led to the concept of postmenopausal osteoporosis, where a lack of oestrogen 
production is believed to affect the calcium metabolism. This again affects bone remodelling 
processes, eventually leading to osteoporosis. 
 Although Albright’s model was widely accepted, it had limited impact in terms of 
diagnosis and treatment of osteoporosis. This limitation was due to a lack of measurement 
tools that could produce the necessary diagnosis of osteoporosis. It thus remained an enigma 
for several decades, as its only confident detection could be made by the occurrence of an 
osteoporotic fracture. Further research within this biological framework identified oestrogen 
imbalance, calcium deficiency, aging and heredity as the major causal factors behind 
osteoporosis.  
 As a consequence of these unfruitful developments, researchers eventually turned their 
attention towards early diagnosis of osteoporosis, in an effort to identify the best methods of 
prevention. Among the challenges faced in the transformation of the medical focus from 
causality to prevention, was the resolution of the definition of asymptomatic osteoporosis. 
This definition was based on the notion of osteoporosis as a statistical deviation disorder, and 
the bone status of the young population was given a central position. 
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 The identification of asymptomatic osteoporosis was achieved through bone density 
measurements. Although technology for such measurements had been available earlier, the 
technological breakthrough in this field is related to the introduction of the DXA-machine in 
the late 1980s. Despite critical voices, this technology has since been at the centre of attention 
in the medical understanding of osteoporosis. 
 Central to this transformation was the shift from an individual focus on osteoporosis to 
one of populationbased epidemiological research. Recognized as a public health problem, 
osteoporosis became a topic for consensus conferences, identifying menopause as a time for 
identification of women at risk of developing osteoporosis. This new approach to osteoporosis 
originated in the USA, but has since spread worldwide. 
 
Further efforts in seeking consensus about the definition of osteoporosis and the identification 
of the population that would benefit from early diagnosis eventually lead to the official 
definition of osteoporosis by the WHO in 1994. According to this definition osteoporosis is a 
bone mineral density value 2.5 standard deviations below the mean of the young adult 
reference range. This cut-off point was chosen as it was believed to be the point most 
accurately identifying those at risk of having osteoporotic fractures. Despite being widely 
discussed in the current medical literature, the WHO definition of osteoporosis has retained its 
hegemonic position in modern medicine. 
 The history of the transformation of the medical understanding of osteoporosis in the 
latter half of the twentieth century thus serves as a prime example of how the notion of risk 
has made a defining impact on the diagnosis of osteoporosis. 
 
Paper III  
Skolbekken, J-A. Risk reduction on the drug reimbursement scheme (Unpublished 
manuscript2). 
                                                            
2 An earlier Norwegian of this manuscript was published in Norwegian in an anthology about risk (Skolbekken, 
2001). (My translation). 
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The aim of this paper was to critically examine what in Norway became known as the 
Fosamax-case, which concerned the inclusion of a drug against osteoporosis in the drug 
reimbursement scheme. It is described against the background of public health as a common 
ground for many interests, but also as a battleground for conflicting interests. In this particular 
case the conflict was between the health authorities and a drug manufacturer, but it also 
involved doctors, patients, politicians and the media. 
 Knowledge about risk and its reduction is at present important in the discourse around 
preventive medicine. It is used by both health authorities and the pharmaceutical industry in 
their efforts to legimitize their interventions on people who otherwise perceive themselves as 
healthy. In the Fosamax-case the Norwegian health authorities and a multinational 
pharmaceutical company clashed on the interpretation of the efficacy of a drug that had been 
proven to reduce the risk of vertebral fractures in a randomized controlled trial. This 
disagreement was about the interpretation of the outcome of this research, but also a conflict 
between different economical interests. 
 The publicly available story of the Fosamax-case unfolded in the columns of the 
newspaper Aftenposten. In the initial phase of the story the health authorities were presented 
as the villains, denying suffering old ladies available treatment against osteoporosis. This 
treatment was provided by a drug manufacturer, who was denied their rightful economical 
compensation for their efforts in producing the most effective measure against osteoporosis. 
 A case of social injustice and discrimination of women was apparently resolved when 
the Norwegian parliament decided to bypass the health authorities and include Fosamax in the 
drug reimbursement scheme. This outcome was the achievement of a broad political coalition 
of female MPs. 
 Not long after this decision a new story was presented, indicating that the decision had 
been somewhat premature. Now experts appeared to tell about hitherto hidden facts that had 
not been taken into consideration before the parliamentary decision had been made. As a 
consequence the roles changed, as the pharmaceutical company now became the villain of the 
story. The climax of the case came when the company tried to stop the health authorities from 
publishing their health economical analysis about Fosamax by a court order. 
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Paper IV  
Skolbekken, J-A., Østerlie, W. & Forsmo, S. (2008). Brittle bones, pain and fractures - Lay 
constructions of osteoporosis among Norwegian women attending the Nord-Trøndelag Health 
Study (HUNT). Social Science & Medicine, 66, 2562-2572. 
 
According to the medical literature there are serious deficits in lay people’s knowledge of 
osteoporosis. This conclusion is based on studies that measure women’s ability to reproduce 
medical knowledge of osteoporosis. It does not, however, reflect people’s understanding of 
osteoporosis in a wider social and cultural context. 
To gain further insight into women’s knowledge and beliefs about osteoporosis was 
the aim of this study, done amongst women undergoing bone density measurements as part of 
a follow-up of the Nord-Trøndelag Health Study (HUNT). 
Pain was recognized as the most defining characteristic of osteoporosis, which was 
pictured through an old, bowed woman. More modern tales about the condition included a 
sneaking and invisible condition. Despite being acknowledged as a condition that had been 
around for a while, it was seen as one that only recently had been given its rightful 
recognition. This recognition was seen as a feminist breakthrough, as it had hitherto been 
outside  medical and public attention due to its low status as a disease mostly affecting 
women. 
A rising incidence of osteoporosis was attributed to the aging of the Norwegian 
population. Although chiefly a women’s disease, anecdotal evidence also confirmed the belief 
that men could get osteoporosis. Falling played an important role in the women’s assessment 
of their personal candidacy for osteoporosis, underscoring the significance of their lived 
experiences for these assessments.  
Previous bone density measurements had led some of the elderly women to perceive 
themselves as fragile and porous, although they had no bodily experiences confirming this 
perception.  Feedback from the bone density measurements provided confusion among the 
women, leaving them in dependence on professionals for information and reassurance. 
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A healthy diet and exercise were frequently described as factors that could prevent 
osteoporosis. Exercise was seen as a double edged sword, as it was hard to fit into the 
schedule of the modern double working woman. It thus became a source of bad conscience. 
Oestrogen therapy was also among the factors mentioned to have a preventive function. 
Whereas this measure was perceived as positive among the younger women, the older 
women’s perception of it was clearly negative. 
The origins of osteoporosis were described differently across generations, and with 
varying moral attributions. In the generations before them, the women saw osteoporosis as the 
outcome of the hardships of manual labour outside the control of those affected by it. In their 
own generation osteoporosis was seen as the outcome of a stressful, modern life. Although 
perceived as potentially controllable, their busy modern lives provided ample excuse for not 
making the most of this opportunity of prevention. No excuses were made for the present 
young generation, however, who were portrayed as being outright lazy with questionable 
eating habits, thus failing to exercise the expected self-governance. 
 
Paper V  
Skolbekken, J-A., Østerlie, W. & Forsmo, S. Risk categorization through standard deviations 
– the challenge of bone density measurements. A focus-group study among women attending 
the Nord-Trøndelag Health Study (HUNT). Health, Risk & Society (Accepted for 
publication). 
Bone density measurements are central in the medical pursuit of early identification of 
osteoporosis. A prerequisite for this task is professional agreement about the categorization of 
osteoporosis. In this study aimed at scrutinizing the challenges facing lay people in their 
interaction with disease categorization based on risk estimates, lack of unified categorization 
proved to be a substantial challenge.  
For the majority of women the bone density measurements were perceived as much 
more important just before and after the actual measurements, than they were six months later. 
In this sense undergoing a bone scan did not make very lasting impressions on them, as they 
were mostly told that their bone status was OK. 
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Prior to the measurements we noticed considerable variation in the women’s 
expectations. A relaxed attitude was common, whereas among women who perceived their 
personal risk to be high expectations were tenser.  For them the time before the scan 
represented a flux between hope of reassurance and fear of diagnosis. In general the 
opportunity of having a scan was seen as favourable.  
Despite this the scans proved a fearful experience for some, as did the participation in 
the focus groups. This latter experience was related to the discovery of knowledge about 
preventable measures known by their peers, but not by themselves. To discover that one’s 
bone mass had diminished despite following professional advice about a healthy lifestyle, was 
another negative experienced among our participants. 
To comprehend the measurement outcome which was communicated in terms of 
standard deviations proved an insurmountable challenge in all of the focus groups. Not be 
able to make sense of the scores themselves, they were left at the mercy of the interpretation 
communicated to them by the professional staff at the scanning stations. The bone scan results 
also tended to undermine the value of their own lived experience, generating an insecurity 
leading several of the women to make private appointments for new scans. 
Another reason for having a new scan was lack of trust in the measurements provided 
by HUNT. Their scans covered the wrist, whereas other bone scan providers offered scans of 
greater parts of the body. These scans were perceived as more trustworthy, a belief also 
supported by other health professionals the women had contacted. Further distrust in the bone 
scans were generated by the fact that HUNT and other institutions offering bone scans made 
different categorisations of osteoporosis. As a consequence some of our participants were told 
that they were osteoporotic by some professionals, whereas others told them that they were 
not. 
 
Paper VI  
Skolbekken, J-A. (2008). Unlimited medicalization? Risk and the pathologization of 
normality. In A. Petersen & Wilkinson, I. (Eds.) Health, Risk and Vulnerability. (pp. 16-29). 
London: Routledge. 
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The aim of this text is to present a critical analysis of developments in the past decade, which 
can be seen as an escalation of the medicalization of life. This escalation has come through 
the pathologization of normality and the removal of the divide between preventive and 
clinical medicine. Risk calculations combined with chemical modes of prevention are central 
in the way reality is ordered in modern medicine. 
Whereas risk is outside the realm of our bodily experiences, it can be mediated 
through risk measurements and calculations. As part of a surveillance medicine designed to 
protect us against our unavoidable vulnerability, it is a constant reminder of just that 
vulnerability. Factors that tend to be easily measured, calculated and then manipulated have 
been given central positions in our efforts to control life itself. In the pursuit of this control the 
criteria for medical interventions have been substantially expanded, through the construction 
of pre-diseases. This has been achieved through the pathologization of normality. 
In recent times we have witnessed what may be seen as the success of preventive 
medicine. This success is based on the development of various pharmaceutical products which 
have been proven effective through their risk reducing effects. To identify individuals in need 
of this chemical prevention computer programs have been developed. Promoted as news 
articles about research findings, appeals are made not only to healthy citizens, but also clearly 
to modern health consumers. In this communication a message of control is given priority 
over messages of uncertainty.  
Whilst several observers have attributed a more central role to the pharmaceutical 
industry recently, it is clear that the observed escalation in medicalization is that it appeals to 
several actors in society. Backed by a scientific rationality and representing a sound business, 
appealing to the consumerist ethos, framed within the rights of the citizen and the duties of 
civil society, the potential of medicalization seems unlimited.  
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DISCUSSION 
The findings and reflections from my six papers focus on various facets of modern medicine. 
The subjects under study can be seen as interrelated in many ways, as can the papers. A 
common feature of all the papers is that they are concerned with risk and medicalization. 
Three of the papers (I, II, and VI) cover these themes on an international basis, related to 
biomedicine as a global enterprise, whilst the rest (III-V) are focused on related themes within 
a Norwegian context. Osteoporosis is covered in all the articles from the Norwegian context, 
as well as paper II on the historical development of the medical understanding of osteoporosis. 
A historical perspective is also presented in paper I on the risk epidemic, whereas the rest of 
the papers have their focus in a more detached time-frame. Three of the articles (I, II and VI) 
are studies of professionally based representations whereas the focus groups study (IV and V) 
is based on lay people’s views. Last, the paper on the Fosamax-case (III) involves the media 
representation of many voices, lay and professional.  
Paper I gives furthermore a background picture for the study, whereas paper II-V 
present different sides of osteoporosis as an example of how the risk discourse has become 
central on various stages in society, before returning to the more general picture in paper VI.  
In this section of the thesis I will discuss some of the issues that are raised in the 
papers, in an effort to demonstrate how they can be seen as contributing to the themes of risk, 
medicalization and osteoporosis. It takes the risk epidemic as a starting point, as a potential 
for making virtually everything statistically associated with a negative outcome a ‘thing 
medical’. Then the focus turns to osteoporosis in an attempt to offer explanations for the 
medicalization of osteoporosis, including limits to this medicalization. Furthermore, the 
consequences of screening for osteoporosis are discussed. Methodological reflections are then 
offered, before some final reflections are made. These reflections cover such topics as lay 
acceptance and professional resistance against medicalization in Norway, alternatives to the 
risk discourse, and finally reflections on the dilemma of modern medicine. 
 
The risk epidemic and the potential for medicalization 
In the introduction to Paper I it was noted that the present preoccupation with risk seemed 
paradoxical given the present state of health affairs in the Western world. Taking the 
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governmentality perspective into consideration, the situation may not be paradoxical at all. 
Risk provides an opportunity of control through calculative rationality (Dean 1999ab), thus 
the medical literature on risk has become a vital part of the governance of ourselves and 
others. 
 As noted in the paper a substantial increase in the number of published risk articles 
appeared from the mid-1980s. It is perhaps accidental, but this provides an almost perfect 
correlation with Clarke’s (2010) dating of the start of biomedicalization. Without further 
investigations this remains an issue for clarification, but it is outside the scope of my present 
work. There are stronger reasons to claim that the risk epidemic provides ample opportunity 
for the expansion of medicalization as described by Conrad (2007). How this expansion may 
happen through the expansion of what are defined as treatment groups was also discussed in 
Paper VI. The potential for medicalization comes from the way risk blurs the dichotomy 
between healthy and sick, normal and pathological. This leaves plenty of room for negotiating 
cut-off points for intervention, reflecting that these are modern ways of constructing health 
and illness. 
A most striking feature of the risk epidemic is the actual number of risk articles that 
has been published. Also taking into consideration that the vast majority of articles that have 
been published are not risk articles, it seems safe to conclude that we are witnessing what has 
been called ‘Big Science’ (Price 1986). This illustrates that research has taken industrial 
proportions, providing considerable challenges for people that try to stay updated on the 
research in their own limited field. Then again, this also illustrates that research serves other 
purposes than the accumulative gathering of knowledge, career building being one of the 
obvious candidates. 
As mentioned in Paper I, information technology is a pivotal instrument for the 
development of the risk epidemic. The rise in calculation power and the distribution of 
computers in society over the last couple of decades should not be underestimated when we 
seek to explain why there have been published more risk articles in the first decade of this 
century than the accumulative publication in all the preceding centuries. Calculating 
disciplines such as epidemiology and clinical epidemiology have contributed with their fair 
share of papers, as have recent developments in genomics.  
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In addition to the disciplines providing the numbers, the risk epidemic is also fed 
through a considerable number of papers offering interpretations of the numbers, whereas 
others are produced in an effort to disseminate numbers. As there is no general agreement on 
the interpretation of the numbers, this has stimulated further publications involving disputes 
over their interpretation. Add to that a considerable amount of papers that are being published 
about risk communication, which has become ‘the main work of doctors.’ (Smith, 2003). 
Ironically, the research presented in this thesis comes within this category of research that 
lives off and contributes to the risk epidemic.  
 Returning to the issue of the potential for medicalization, we can observe that just as 
surveillance medicine can lead to the definition of every human as ‘potentially sick’, so 
everything identified as a ‘risk factor’ carries the potential for medicalization. This is the basis 
for the medicalization of everyday life. Some risk factors carry a greater potential for 
medicalization than others. As has been argued in several of my papers this can be seen as 
particularly true for those risk factors that can be measured by a specific medical technology 
and also be reduced by a pharmaceutical intervention. In the next part of the discussion I will 
try to illuminate this further by using the example of osteoporosis, with support from 
historical observations about similar risk factors.  
 
How can the medicalization of osteoporosis be explained? 
As can be seen from the above question I take the medicalization of osteoporosis as a fact 
(sic). It can be argued, however, that this has happened three times over and in somewhat 
different manners, as part of the medicalization of everyday life, as part of the medicalization 
of menopause, and finally as the specific medicalization of osteoporosis. (As a matter of 
convenience I will refer to this medicalization as the medicalization of osteoporosis in the 
remainder of the text). These three forms of medicalization can be seen as co-existing. Before 
explaining this I will furthermore claim that osteoporotic fractures have never been 
medicalized, but have been a ‘thing medical’ for as long as we know. By this I mean that I do 
not know of other ways of handling fractures than within the frame of health and illness. 
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Three forms of medicalization 
 The first form of medicalization including osteoporosis can be seen as coming through 
the medicalization of everyday life, wherein osteoporosis is on the list of diseases to be 
prevented by a ‘healthy’ lifestyle. In accordance with the identified risk factors for 
osteoporosis, such a lifestyle should include a diet rich on calcium and vitamin D, bone 
strengthening exercises, abstinence from smoking and a moderate alcohol consumption 
(Ballard & Purdie, 1996).  
Secondly, osteoporosis became a part of the medicalization of menopause through its 
aetiological connection with the discontinuation of oestrogen production in women. This 
medicalization originated from the ‘discovery’ of sex endocrinology in the first half of the 
20th century (Bell, 1987). The introduction of the first synthetic oestrogen paved the ground 
for hormone replacement therapy (HRT), on the basis of the understanding of menopause as a 
situation that represents a hormonal deficiency. Although originally prescribed on 
symptomatic indications, the list of indications for HRT changed and expanded over time 
(Palmlund, 1997a). The link to osteoporosis is based on the understanding of oestrogen 
deficiency as representing a risk factor for osteoporotic fractures, which can be reduced by 
oestrogen treatment (Palmlund, 1997b).  
 The medicalization of menopause, defining all women as suffering from a bodily 
deficiency in the latter half of their lives, has been heavily criticized. Its adverse consequences 
on women’s health and well-being have been characterized as ‘enormous’ (Meyer, 2001). 
Without going into the substantial literature on this issue, the point worth noting here is that 
HRT in retrospect has survived despite heavy criticism over many decades (Krieger, et al. 
2005). Despite recent setbacks through the publication of the results from the Women’s 
Health Initiative study, demonstrating that HRT can lead to an elevated risk of both coronary 
heart disease and breast cancer (WHI, 2002), current claims are still made that “estrogen 
replacement is an obvious treatment approach to counter the problems associated with the loss 
of ovarian function and subsequent estrogen deficiency.” (Stevenson, 2011:197). The 
medicalization of menopause, and thereby osteoporosis, can thus be seen as a form of 
medicalization that has become limited compared to the time prior to the WHI-study. Thus it 
would be premature to state that we have witnessed a demedicalization of menopause. 
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 The third, and specific, form of medicalization has come from the research identifying 
the loss of bone mineral density as a risk factor for osteoporosis.  
 
The specific medicalization of osteoporosis 
From a medical perspective great progress has been made in the efforts to treat and prevent 
osteoporosis over recent decades. This progress has been attributed to such achievements as 
the ability to diagnose osteoporosis before fractures occur, the efficacy of bisphosphonate 
treatment and the establishment of the WHO-definition of osteoporosis (Blake & Fogelman, 
2010). Three such concurrent achievements may be seen as the result of a master plan. One 
way of explaining the current situation would therefore be to see it as the outcome of ‘disease 
mongering’ – “trying to convince essentially well people that they are sick…” (Payer, 1992:5). 
Recent developments have further been described as the outcome of the efforts the marketing 
departments of the pharmaceutical industry (Moynihan & Cassels, 2005).  
In the American context the pharmaceutical industry has made dedicated efforts in 
putting the treatment and diagnosis of osteoporosis together. According to Grob (2011) the 
pharmaceutical industry funded much of the osteoporosis research. In an effort to aid people 
unaware of their need of treatment for osteoporosis in its direction, the manufacturer of 
Fosamax invested in a bone scanning equipment manufacturer prior to putting the drug on the 
American market. Having thus prepared the ground for the scans, the company furthermore 
financed a toll-free phone number that the public were informed about through direct-to-
consumer advertising on television (Fausto-Sterling, 2005). Similar tactics, including fear 
arousing, have also been described to motivate American women for bone scanning and 
treatment against osteoporosis (Kazanjian, Green, Bassett & Brunger, 1999). 
 As has been pointed out, however, it is too simple to reduce this form of 
medicalization to “a clever marketing effort or a centrally planned form of medicalization…” 
(Greene, 2007:5). Without denying that the above achievements may have been planned, or 
that pharmaceutical marketing is effective, it can also be argued that the fulfilment of the 
mentioned achievements are less predetermined than they may seem at first sight. We will 
therefore look closer at the developments leading to the specific medicalization of 
osteoporosis. These developments can also be seen as example of what Abrahams (2010) calls 
the ‘medicalization-pharmaceuticalization complex’. 
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 As shown in Paper II densitometry played a pivotal role in transforming osteoporosis 
from a clinical entity to a risk factor that could be subject to control. It is worth noting, 
however, that it did not take just any form of densitometry to accomplish this, but 
densitometry in the shape of the DXA scanner (Fogelman & Blake, 2005; Griffith & Genant, 
2008). The craving for such a technology had been there for some time, but it had not been 
fulfilled. This illustrates that although technology can be claimed to be central to the invention 
of a disease (Hofmann, 2001), it takes the right technology to be introduced at the right time. 
This point is illustrated by other technologies that are presently used to identify people at risk. 
Although serving that purpose today, this was not always the case. One example is the ‘Pap 
Smear’ which at present is an established tool for cervical cancer screening. This technology 
was available for half a century before being accepted as ‘the right tool for the job’ (Casper & 
Clarke, 1998).  
 The sphygmanometer is another instrument that was around for more than half a 
century before it became the tool we know it as today. Introduced early in the 20th century and 
widely distributed and used by medical doctors in the USA for life insurance purposes, it was 
not until the discovery of drugs with the ability of lowing blood pressure that it became a tool 
for the identification of people in need of antihypertensive treatment (Greene, 2007). 
 Greene’s (2007) account of the history of hypertension also shows that even when 
possible to lower a patient’s blood pressure, it was not necessarily seen as an acceptable 
option as it for a long time was seen as unethical among doctors to lower a person’s blood 
pressure. A reason for this was the belief that a high blood pressure was the heart’s adaptive 
process when faced with the challenge of squeezing blood through hardened tissues. To 
interfere in such a natural process was thus perceived as wrong. 
 The simplistic notion of medicalization by means of a master plan is further refuted by 
the knowledge that the antihypertensive effect of thiazides was discovered by accident. As 
Greene (2007) points out, the same happened to be the case with the drugs that later became 
central in the medical construction of what has become diabetes II. Summing up, the 
historical examples of the social construction of hypertension, diabetes II and 
hypercholesterolemia illustrates very well how what we today may perceive as taken for 
granted examples of disease mongering, as the outcome of complex processes that have 
developed over time. Drugs and diagnostic technology are central ingredients in these 
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histories, and the pharmaceutical industry a central actor, but these developments are far from 
linear. In this manner the analysis of expanding categories of treatment groups through the 
pathologization of normality (Paper VI) is limited to the present, whereas it could have 
benefited from a more historical approach. 
 Returning to osteoporosis, the second factor contributing to the perceived medical 
success is the efficacy of bisphosphonate treatment, which has become the most established 
drug against osteoporosis. As with other drugs that at present serve to treat risk factors that 
have become diseases in their own right, bisphosphonates come with a history. Although 
discovered late in the 19th century (Petroianu, 2011), it was not until well into the second half 
of the 20th century that they were used for medical purposes (Graham & Russell, 2011), and 
their introduction as a treatment for ‘postmenopausal’ osteoporosis came as late as 1976 
(Eastell, et al. 2011).  
 The perceived efficacy of bisphosphonates has been established through randomized 
controlled trials. It was one of the first trials, the Fracture Intervention Trial (FIT) (Black, et al. 
1996), which was involved in the controversy between the drug manufacturer and the 
Norwegian health authorities in the Fosamax-case (Paper III). As described there, and also in 
another paper about the communication of the risk reducing effect of other drugs (Skolbekken, 
1998), there are reasons to challenge perceptions of drug efficacy based on the 
communication of relative risk reductions alone. Despite this, it is now the established view in 
medicine  that the efficacy of bisphosphonates is well proven (Eastell, et al. 2011). 
 The last achievement seen as contributing to the successful treatment and prevention 
of osteoporosis is the WHO definition (Kanis, et al. 1994). This categorization provides a 
standardization of the risk of osteoporosis, preparing the ground for the identification of 
individuals seen as being in need of a medical intervention (Wylie, 2010). Although vital in 
the establishment of the WHO classification, the ability of bone density measurements to 
predict the occurrence of osteoporotic fractures has since been shown to be far from perfect. 
As a consequence, its suitability as a screening instrument has been questioned (Marshall, 
Johnell & Wedel, 1996).  
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A possible next step in the medicalization of osteoporosis 
In the period from the establishment of the WHO definition research has been performed to 
identify other risk factors that can be applied in the prediction of osteoporotic fractures. This 
research has contributed to the development of the Fracture Risk Assessment Tool (FRAX®) 
(Kanis, et al. 2010). The application of this instrument serves the goal of identifying the 
individuals that should be offered treatment, and has been developed at the WHO 
Collaborating Centre for Metabolic Bone Diseases at Sheffield University. In addition to 
BMD, FRAX® includes such clinical risk factors as age, previous fractures, low body mass 
index, parental history of hip fracture, smoking habits, alcohol intake, use of drugs known to 
increase the fracture risk, among others. The instrument calculates the 10-year probability of 
hip fracture or a major osteoporotic fracture. It is freely available for use by anybody with 
internet access, and is located on the webpages of Sheffield University. In addition it is also 
available as an app for Iphone and Ipad. This enables a lot of people to calculate their own 
risk of an osteoporotic fracture, with the exception of one element - they still need to measure 
their BMD at a testing site. Until now, that is. 
In a most recently published review, Kanis, et al. (2012) have concluded that it is now 
feasible to predict fractures by using the clinical risk factors in FRAX alone, so that BMD 
measurements are no longer necessary when making these predictions. This has wide 
implications and the FRAX-group highlights the possibility of making predictions widely 
available in countries with sparse facilities for BMD-testing. Considering the scenario that has 
depicted osteoporosis as an epidemic on the rise in some of the densest populated areas of the 
world, this can be seen as another important breakthrough. 
 An alternative interpretation is that we are witnessing an important step in the 
development of the medicalization of osteoporosis. As was described in Paper II, BMD has 
played a crucial job in the development of getting osteoporosis established as a risk factor. It 
became the chosen technology because of its perceived speed, accuracy and economy. With 
the new directions in the research related to the development of FRAX, an even cheaper, 
speedier and more economical approach has arrived. Described as a tool intended for primary 
health care, BMD-scans can now be replaced by a visit to the GP who will be able to offer the 
relatively simple screening test that FRAX is becoming. Knowing that FRAX is now also 
available through information technology, osteoporosis screening can now be offered to 
health consumers without involving doctors at the diagnostic stage. Doctors may thus in the 
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future become merely the intermediary, providing the necessary prescriptions. A logical next 
step may also be that drugs believed to prevent osteoporosis can become over the counter 
drugs, eliminating the doctor from the process all together. This fits well with the observation 
that “the growth of medicalization coexists with the diminishing of professional authority and 
power.” (Furedi, 2006:15). For the record; Kanis, et al. (2010) declared no conflicts of interest, 
several of the authors of Kanis, et al. (2012) declared the reception of ‘unrestricted research 
funds’ from a host of pharmaceutical companies. 
 Before moving on to the limitations of medicalization, there is time to place Paper III 
within the above context. One interpretation of the Fosamax-case is that it can be seen as an 
example of the pharmaceutical industry’s disease mongering tactics. At one level there was a 
dispute over calculative rationality, in the form of different interpretations of the efficacy of 
the drug expressed in messages about risk reduction. This dispute was mainly between the 
professional parties in the conflict. 
 Not being able to win this dispute, the company demonstrated that its repertoire was 
wider than the appeals for calculative rationality. By framing the case as a political issue 
involving social injustice and discrimination against women, alliances were formed which 
enabled the company to fulfil its ambitions by bypassing the health authorities. 
 It is tempting to see the case as an example of how American tactics of medicalization 
were applied in Norway. Such tactics may also be seen as playing an important role in the 
final outcome, as the frequently used American tactic of taking ones opponents to  court 
backfired on the company. 
 
Limits to the medicalization of osteoporosis 
From the above it can be concluded that the pharmaceutical industry is an important actor in 
medicalization, which has also been observed by others (Conrad, 2005). Even so, there is also 
ample evidence that there are limitations to the medicalization promoted by this industry. If 
osteoporosis were to be fully medicalized we would expect to see a pattern wherein people 
would be knowledgeable about the risk of osteoporosis, the measures to be taken to prevent it, 
and the drugs that are available to treat it. Furthermore, such knowledge would be matched by 
a healthy lifestyle, adherence to screening, and compliance to therapy when needed. It could 
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also be argued that such knowledge and behaviour would be in accordance with 
governmentality. As we shall see, this is not the case. 
 Knowledge about osteoporosis is seen as a prerequisite for its successful prevention, 
although other factors are seen as equally important for preventive behaviour to occur. Studies 
from around the world has been summed up as painting a rather glum picture, as knowledge 
about prevention, therapy and the consequences of osteoporosis are characterised as generally 
poor (von Hurst & Wham, 2007). 
In addition it has been shown that women underestimate their risk of osteoporosis 
(Gerend, et al. 2006), which is seen as impeding their screening behaviour (Nayak et al. 2010). 
Such findings are not unique for the risk of osteoporosis, however, and several psychological 
mechanisms have been suggested as explaining why people do not feel personally at risk 
(Chambers & Windschitl, 2004; Taylor & Brown, 1988; Weinstein, 1980). What has been 
labelled as poor risk awareness has also been observed among women who have been 
diagnosed as having osteoporosis, including those taking medication against osteoporosis 
(Siris et al. 2011). 
When lay people’s knowledge of osteoporosis is characterised as deficit (Giangregorio, et 
al. 2010), limited (Costa-Paiva, et al. 2011), inaccurate and insufficient (Jalili, Nakhae, Askari 
& Sharifi, 2007) in the professional literature, it is interesting to notice what is defined as 
knowledge in this literature. A striking feature is that what goes as knowledge in the medical 
literature is mainly seen as right or wrong notions of osteoporosis. Among answers perceived 
as wrong is a disease of the bones without further specification, describing it as a crippling 
disease, or as a disease resulting in a crooked spine without telling that it is a disease of the 
bones. Believing that ‘walking has a great effect on bone health’ is wrong according to NIH 
guidelines, although this is characterised as confusing by the researchers (Giangregorio, et al. 
2010). Another conclusion from this Canadian study is that the participants’ knowledge was 
even poorer on risk factors for osteoporosis than for osteoporosis as a manifest disease. 
 Somewhat opposite conclusions to the global picture have been drawn about the 
knowledge about osteoporosis among Norwegians. A national survey indicated that the 
knowledge of osteoporosis and its consequences were generally high among both men and 
women (Magnus, Joakimsen, Berntsen, Tollan & Søgaard, 1996). Furthermore knowledge 
was found to be higher among women than men, and higher among the young and the well-
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educated. Looking at the questions posed in this survey, however, there is reason to believe 
that the Norwegians passed an easier test than their counterparts in other countries.  
 Reviewing the medical literature studying knowledge about osteoporosis, Werner 
(2005) concluded that it was characterized by a lack of theoretical framework and 
methodological flaws. These flaws were mainly defined from a positivist position, addressing 
such issues as lack of randomization, cross-sectional design, and so on and so forth. Reading 
the review from another perspective, it can also be argued that a problem with this literature is 
that it is decontextualized and reductionistic, which leads to a limited comprehension of lay 
people’s understanding of osteoporosis. 
In biomedical terms the knowledge of osteoporosis is a universal knowledge, valid all 
around the world. Qualitative studies provide illustrations of how this knowledge is 
interpreted within a cultural frame, however, as when the late Danish Queen Mother became 
an icon for osteoporosis in Denmark (Reventlow & Bang, 2006), and when falling over on icy 
pavements has become a real life test for osteoporosis in Norway (Paper IV). One limitation 
to the medicalization of osteoporosis may thus also be seen as coming from medicine’s failure 
to look outside the box of calculated rationality. 
 Looking outside this box it has been observed that middle-aged women show little or 
no interest for osteoporosis (Backett-Milburn, Parry & Mauthner, 2000). In this group 
knowledge about osteoporosis was greater among those having personal experience with 
osteoporosis in their local community and social network than among those without such 
personal points of reference. Furthermore, this study showed that what the researchers 
interpreted as resistance against medicalization was based on the everyday experience of lives 
filled with more pressing issues than their future risk of osteoporosis. This illustrates that one 
of the major limitations for medicalization in modern society is the lack of time available for 
it. Time available for the medicalization of everyday life, that is. As medicalization in the 
form of chemoprevention is less time consuming, this could become a more appealing form of 
medicalization, as has been observed in the US (Greene, 2007). Such appeals have also been 
observed as part of the disease mongering repertoire of the pharmaceutical industry, by means 
of advertising campaigns telling that efforts to achieve lifestyle changes are basically in vain, 
making chemoprevention a more viable option (Malterud, 2002). 
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 The cultural context also plays an important part in the medicalization of osteoporosis, 
which is illustrated in Paper IV. As indicated in the paper both the Norwegian Women’s 
Public Health Association and the HUNT Research Centre have contributed to this in Nord-
Trøndelag. Among our participants, accepting the screening offered by these two actors was 
perceived as a benign form of medicalization, i.e. medicalization was not a word mentioned in 
the focus groups. We noted only one limitation among our participants, the experience based 
resistance against HRT among the elderly women. 
 As the Scottish women our participants expressed a limitation to the medicalization of 
everyday life as there was limited time for it. Their report of bad consciences for not living up 
to the perceived expectations of the health promoters indicated that they  had accepted the 
idea of medicalization through self-governance. Furthermore, they reported to a much larger 
extent than the Scottish women knowledge about the lifestyle expected to prevent 
osteoporosis. These differences can be seen as reflecting the different position of osteoporosis 
in the respective cultures, but it may also reflect differences in the research designs. Whereas 
the Scottish study had a low profile about osteoporosis as the theme of interest, osteoporosis 
was the prime concern in our study. Ironically, the awareness created by  participation in 
HUNT, and in follow-up studies like our own, can clearly be seen as contributions to the 
medicalization of osteoporosis. 
 A final limitation to medicalization to be mentioned under this section is the 
possibility of the existence of a ‘screening saturation’. This has been illustrated by a Belgian 
survey among female employees at a university hospital. Despite showing a high uptake on 
various medical screening procedures, including pap-smears and mammography, the relative 
uptake on bone density measurements was small (Rozenberg, et al. 1999). This may indicate a 
prioritizing among screening procedures when they are offered in abundance. Again, this may 
be seen as reflecting that there is limited time available for medicalization, even among those 
favouring it. 
 
The limited appeal of drugs against osteoporosis 
Another limitation to the medicalization of osteoporosis is the failure of patients that have 
been prescribed drugs against osteoporosis to actually take their tablets. This situation is not 
unique for this kind of medication, but can be seen as a universal phenomenon. In real life this 
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threatens the efficacy of drugs that have been proven to be so in RCTs. Compliance, 
persistence and adherence are the medical terms used to describe the patient’s behaviour in 
relation to medical instructions. Adherence is the combination of compliance (the taking of 
the pill) and persistence (the length of time the pill is taken) (Lee, Glendenning & Inderjeeth, 
2011).  
In a recent review, poor compliance is summed up as a major problem related to 
bisphosphonates. Many patients stop taking their medication, in particular during the three 
first months. Although this behaviour can be seen as the outcome of forgetfulness, it was 
further concluded that in most cases it is the deliberate choice of the patients to stop the 
medication. The reasons for these choices can be such factors as direct experience of adverse 
effects, believing that the risk of osteoporosis is small, scepticism about the effectiveness of 
the drugs, worry about long term side effects and not being able to afford continued 
medication (Silverman, Schousboe & Gold, 2011). In the professional literature 
bisphosphonates are described as generally safe, with few serious side effects. The most 
common side effect, however, is gastrointestinal pain which is perceived immediately. This is 
the most common reason given by patients who stop taking their medication (Pazianas & 
Abrahamsen, 2011). Non-compliance has also been found to be a problem related to the 
consumption of calcium and/or Vitamin D (Sanfelix-Genovés, et al. 2009). 
Our study did not cover this topic, but there are indications that non-compliance is less 
of a problem in Norway than what has been reported elsewhere. A study based on data from 
the Norwegian Prescription Database has shown that ¾ of the users of drugs against 
osteoporosis refilled their prescriptions annually over a three year period. Another noticeable 
finding from the same study is that the Norwegian counties with the lowest incidence of hip 
fractures are the counties with the highest prescription rates. As the incidence rates are 
historically based, they are not the outcome of the drug use (Devold, et al. 2010). This may 
thus be seen as a local Norwegian pattern of medicalization. According to the study some of 
the lowest prescription rates were observed in the two Norwegian counties without DXA-
machines.  
Identification of the people in need of osteoporosis treatment is at present seen as a 
crucial step in the prevention of osteoporotic fractures (Kanis, et al. 2010), and securing the 
patients’ understanding of their bone scan outcome is furthermore seen as a prerequisite to 
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ensure persistence with osteoporosis therapy (Brask-Lindemann, et al. 2011). In the medical 
literature BMD measurements are mainly understood within this frame of reference. Below 
we will present data from a different frame of reference; that of bone scans as experienced by 
the women being scanned. 
 Before doing so it is worth nothing that limitations mentioned above are not the 
outcome of an ideologically based resistance against medicalization, as was the case with the 
medicalization of menopause and other natural processes of the female body. As was shown 
in Paper III the parliamentary decision to put Fosamax on the drug reimbursement scheme 
was at first hailed as a feminist victory. Similarly, the participants in our focus groups also 
saw their bone density measurements as a being a feminist victory (Paper IV). From this it can 
also be possible to make a distinction between two sorts of limitations to medicalization, the 
intended and the unintended. 
 
What are the consequences of screening for osteoporosis? 
As observed in the introduction, questions have been raised  about whether there exists a 
pathology of prevention (Sachs, 1995). This question was based on the observation of what 
happened when people feeling perfectly healthy were given feedback about their cholesterol 
levels which labelled them as being at high risk. Faced with ‘scientific proof’ that their own 
bodily experiences were wrong, led to confusion and strong reactions (Adelswärd & Sachs, 
1996). 
This concern was also the main reason for performing our focus group study, and as 
shown in Paper V having a bone scan proved to be a mixed blessing for our participants. The 
majority felt reassured by a negative scan, whereas some experienced confusion and worry 
albeit having a negative scan. This was caused by contradictory messages about their status 
and the trustworthiness of the applied technology. Such concern led to active pursuit of what 
was believed to be more reliable screening results from alternative screening providers. 
Rather than fostering a resistance against medicalization, the craving was for better 
medicalization among those not trusting the technology offered. When comparing our study 
with other studies of women undergoing bone scans, there is good reason to believe that this 
outcome cannot be seen as a generalizable consequence of having a bone scan, but was 
related to the particular context of our study. 
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 Another noticeable effect among our participants was the confusion caused by the 
format of the feedback, by means of standard deviation scores. Confusion has also been 
reported from a group of British women interviewed after bone scans. Their confusion was 
related to an unclear understanding of the outcome of the scans, but also because the scans 
could be interpreted as showing that healthy behaviour had been in vain (Salter, et al. 2011). 
This is similar to effects experienced by our participants and this has also been reported by 
others (Griffiths, 1999; Richardson, et al. 2002). This confusion is not triggered by having the 
scan alone, but by the conflicting messages communicated through health education and the 
actual risk status indicated by the scan. Having a scan may thus undermine the belief in the 
value of a healthy lifestyle. 
 In contrast to these findings, no confusion was reported in a Danish study asking 
women who had had a bone scan of its outcome (Brask-Lindemann, et al. 2011). One 
explanation for this may be that the outcome was primarily given as a diagnostic category 
(osteoporosis/osteopenia) and not as a number that the women had to interpret themselves. 
 Reassurance was another outcome from our study, which has also been noted among 
British women. These women expressed confidence in their screening service, despite 
demonstrating what was described as ‘incomplete understanding’ of the screening outcome. 
This led the researchers to conclude that the women rely heavily on health professionals when 
it comes to defining their individual risk of osteoporosis (Green, Griffiths & Thompson, 2006). 
This is similar to our observation that the perceived reassurance among our participants relied 
heavily on the explicit feedback from health professionals that the scan was ‘OK’. A common 
feature in all three studies is thus the dependency created by the screening, which revives old 
notions of negative medicalization through professional dominance. 
 An even greater dependency on health professionals in relation to BMD measurements 
has been noted among a group of elderly British women (Weston, Norris & Clark, 2011). For 
these women a positive screening result was reluctantly accepted as an inevitable 
consequence of getting older, although the lack of symptoms led them to downplay the 
seriousness of the condition. Despite the described difficulty of understanding the diagnosis, 
they all reported great trust in their GPs, leading them to accept medication for osteoporosis. 
These women were furthermore not aware of other measures to improve their condition than 
taking the prescribed medication. 
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Apart from checking people’s risk status, a leading idea behind scans is that they 
should lead to greater risk awareness and improved health behaviour. The opposite has also 
been shown to be true, as women who have received scanning feedback indicating that they 
are osteoporotic or have lowered bone mass have responded with impaired physical activity 
(Reventlow, 2007). This response is fear aroused, but passivity may not be the only possible 
response. In a group of Swedish women fear has been reported as the basis for what has been 
labelled ‘healthy risk awareness’ which has been described as guiding motivation for risk 
reducing behaviour such as physical exercise (Hjalmarsson, et al. 2007). 
 Scanning feedback to the Danish women was given by means of graphic presentations 
on a screen, and not as numbers (Reventlow, Hvas & Malterud, 2006). These images left 
lasting impressions that were vividly reconstructed years after having the scans. Among the 
most vivid images was the metaphorical image of a collapsing building (Reventlow, et al. 
2008). When the interest in, and recall of, the bone scans faded rather quickly among our 
respondents, this can be explained by the ‘screening negative’ outcome experienced by most 
women in our study, but also by the less imaginable nature of the standard deviation number 
(Paper V). Another quality of the ‘screening positive’ outcome among the Danish women was 
the integration of risk information from the scans into their interpretation of their own bodily 
experiences (Reventlow, Hvas & Malterud, 2006). Once having received the message about 
having osteoporosis, back pain could be interpreted as a symptom of osteoporosis. This can be 
seen as an example of the fusion between risk and disease. Similar experiences were reported 
among our participants that had been told they had osteoporosis on previous scans (Paper IV). 
 A noticeable feature of all the studies discussed above is that they are all European and 
they have all used health surveys as their base for recruiting participants. This influences the 
generalizability of the data, in the sense that there may be a selection bias among the 
participants in these studies. None of them have shown similar impact on  participants as 
those that were found among the Swedish men screened for hypercholesterolemia. A possible 
explanation for this is that the risk of osteoporosis rarely has the drama of immediate lethality 
that can be connected with a risk factor for CHD. Despite this, it seems fair to conclude that 
screening for osteoporosis can have a significant impact on the lives of those that are told that 
they have osteoporosis. 
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METHODOLOGICAL REFLECTIONS 
In this section of the thesis I will present some reflections on the methodology applied in my 
research. Rather than applying a check list approach I will offer critical reflections about what 
I see as strengths and weaknesses of my research. Where I find appropriate I will also reflect 
on such issues as validity, reliability and generalizability of this work. When doing so it will 
be from a social constructionist perspective, acknowledging that these concepts are also social 
constructions and not representing laws of nature (Kvale & Brinkmann, 2009).  
 The main strength of this thesis is that it illuminates the subject of study from many 
angles. In doing so I have taken on the role of what has become known as a bricoleur (Denzin 
& Lincoln, 2011). Portrayed as a handyman, this researcher metaphor can also be described as 
a ‘Jack of all trades’, instead of a master of one. In this metaphor lies also the major strength 
and weakness of this thesis.  
 As mentioned in the description of the methods this research can be seen as containing 
both methodological and data triangulation. Following my explorative travel through the aims 
of the sub-studies it is my conclusion that this triangulation is accidental, or the outcome of 
opportunities taken rather than the outcome of some intelligent scheme I can claim to be my 
own. 
Through its elements of triangulation the study has made it possible to illustrate some 
of the complexity involved in the matters studied. On the other hand, such illumination from 
many sides may also have left spots that have remained in the shadows. The papers of this 
thesis can thus be seen as sub-studies that could have been developed into projects worthy of 
their own, separate PhD-work. 
 
Paper I 
Methodologically the risk epidemic paper can be seen as simple, but solid. It is based on a 
step by step search strategy, whereby its validation was done by checking out questions that 
could invalidate the finding. It is also based on an openly available data source which makes it 
well suited for replication. A replication of sorts has been performed by Heyman & Titterton 
(2010), who have demonstrated the increased frequency of articles combining risk and 
coronary heart disease. 
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Another potential strength of the paper is that it has been well received among other 
researchers. This is illustrated by the number of citations registered in Google Scholar and the 
ISI Web of science, which is 200 and 88, respectively. Without having performed a review of 
the citations, it is my impression from the citing articles that I have read that the citations are 
generally used to establish a fact about the position of risk in modern medical discourse. It 
may have escaped me, but I have not come across texts that question or challenge the content 
of the article. Herein lies a potential problem with using citations as an example of validation 
of the study, as the people citing it may have failed to ask critical questions about it beyond 
the face value of the rising numbers. As Medline covers more than medical journals, there is a 
slight possibility that articles from other sub-disciplines may have contributed to the epidemic 
as well. Checking out the increase in risk articles in specific journals can be seen as a 
validation of the risk epidemic happening in the medical journals, though. 
 
Paper II 
In retrospect the title part “… the historical development of osteoporosis ...” can be seen as 
too ambitious. Replacing “the historical” with “a history of” would have acknowledged that 
there is more than one history about the development of the medical understanding of 
osteoporosis. From a social constructionist position this is perhaps the only truly viable option. 
This point becomes rather obvious when reading the histories published by Wylie (2010) and 
Grob (2011).  
Our own presentation has a further limitation in that it is based purely on the 
academically published literature, whereas Wylie (2010) has had access to some of the central 
actors in the development of the WHO definition of osteoporosis, and Grob (2011) has 
benefited from the use of non-academic publications as well. This has contributed to an 
illumination of the role of the pharmaceutical industry, which is missing in our analysis. A 
possible strength of our paper, however, is that it covers more in depth the various medical 
positions that were held prior to the introduction of the WHO definition. There is, however, 
no indication that what has been presented in the two other studies invalidates our 
observations. 
The three histories cover the topic with variation in focus, and can be seen as 
providing a thick description of the medical understanding of osteoporosis. This description 
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would become even thicker if it were to include the perspectives of other stakeholders as well. 
As with other topics of historical research, there are still numerous other accounts that could 
be given. 
 
Paper III 
As with the previous sub-study this study could have become richer if additional sources had 
been applied. To interview the actors involved in the case would have given access to a 
deeper understanding of their positions. The major limitation to this study is that it depends 
too much on one source – the coverage of Aftenposten. It can thus be seen as giving a valid 
presentation of this coverage, but it cannot be generalized as to telling the complete story of 
the Fosamax-case. Applying both methodological and data triangulation in this study would 
have made it into a proper case study.  
 
Papers IV & V 
In this study we chose focus groups mainly for practical reasons, and we acknowledge that the 
study could have improved if we had been able to combine focus groups with individual 
interviews, as was the case in the Danish studies performed by Hvas and Reventlow. Our 
prospective design made it possible for us to follow the screening experience as a process 
when it happened. We have  come across only one other study with a pre-post screening 
design (Richardson, et al. 2002), which makes our study quite unique compared to other 
studies that have all used retrospective designs, interviewing women that they have identified 
as having received the message that they are osteoporotic. 
 There are two major limitations to the generalizability of our study: that it was based 
on a population of women participating in a health survey, and that another form of scanning 
than DXA-scanning was used in the HUNT survey. The women recruited for our study were 
probably better educated than most women in Nord-Trøndelag, and in particular in relation to 
osteoporosis. Despite this we noticed that many of them came to the focus groups with 
questions they were eager to get an answer to. If this reflected a genuine lack of knowledge 
about osteoporosis, it seems fair to conclude that it is probably lower in other segments of the 
population. Despite these limitations, our data still contains similarities with findings from 
69 
 
other studies, which make it possible to claim that these elements tell something about the 
general experience of screening for osteoporosis. 
 ‘How many participants do we need?’ is the classic question for any research study, 
and in particular for qualitative research (Kvale, 1996). In retrospect we can conclude that we 
included too many in our study, as much of the information we gathered was repeated several 
times over in the various groups. Under other circumstances we would probably have done 
well to stop before we reached nine groups. As our logistics pretty much depended on the 
order of the bone scanning, however, these decisions were not entirely ours to make. From a 
methodological perspective we would have benefited from doing analysis between the group 
sessions, to be able to use these analyses actively in the forthcoming groups. Doing so would 
have made it difficult to follow the logistics of the bone scanning, which is the main reason 
for not starting analysing the data in between group sessions. 
 Furthermore the setting of our study, in particular the questionnaire that the women 
responded to as part of the HUNT study, may have influenced the information that the women 
were sharing in the group discussions. Another factor that may have influenced the 
discussions was the presence of women who were familiar to one another. Although choosing 
towns to avoid this, we noticed that several of the groups contained women who knew each 
other. We did not notice that these prior relationships affected the discussions in particular 
ways, but there is a possibility that some of the participants may have withheld information in 
the presence of other participants whom they knew they would face later outside the group 
settings. 
 Another presence that could influence the participants’ willingness to share 
information was the male moderator. Although remarks about this were made by the 
participants, in particular when ‘feminist issues’ were discussed in the group, it was also clear 
that they considered the moderator as outnumbered. As commented in Paper IV, and in the 
methods and material section of this text, the presence of a doctor claiming to be an expert on 
osteoporosis had a very specific effect. This is an issue that has also  been observed by others 
(Griffiths, 1999; Reventlow & Tulinius, 2005; Hvas, et al. 2005). We believe, however, that 
we handled this situation in a way that benefited both the participants and the study, by 
acknowledging their need for information by providing it at the end of the last group session. 
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 In performing the analysis of our data we strived to achieve a sort of interrater 
reliability. This does not mean that our analysis represent objective facts, rather we see them 
as representing the outcome of our efforts of reaching intersubjective agreement.  
Paper VI 
Although qualitative research is rarely open to exact replication in the manner a chemistry 
experiment would be, to make the methodology as transparent as possible is still an ideal for 
qualitative research. Among the challenges I have faced when writing up this thesis is 
reflecting on what is meant by a critical analysis in this paper. In doing so I have come to 
realise I have done this analysis based on a form of tacit knowledge. In retrospect it seems as 
a type of knowledge I have picked up during my travels in academia, without actually being 
able to point to any specific references. 
 This paper and its analysis can partly be seen as having been subject to a 
communicative validation through its presentation at an international conference, and then 
through the peer review process prior to its publication. In retrospect it is my reflection that it 
would clearly have benefited if the insights offered by Conrad (2007) and Greene (2007) had 
been available at the time when it was written. Then again, that would be asking for the 
impossible. Rather, it should be taken as the best I could do under the circumstances. 
Hopefully the analyses offered in this thesis can be seen as a development and an 
improvement of my previous work. 
 
Ethical reflections 
Most of the texts included in this thesis are texts about other texts, placing them in a different 
ethical category than the two papers that include research on humans.  
 The focus group study was performed according to ethical guidelines, following 
standard procedures for securing autonomy through informed consent and voluntary 
participation, confidentiality through anonymous transcripts, and integrity through respectful 
listening, data analysis and presentation of the research findings. Despite following these 
guidelines, we experienced a couple of issues that caused ethical concern. 
 The first concern was raised when we experienced that some of the women had 
experienced fear as a consequence of participating in the groups. This fear was triggered by 
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the experience of not being as knowledgeable about disease prevention as other group 
members, making them think that they had failed in taking preventative measures against 
osteoporosis. This fear had not prevented them from having their bone scan, however, and as 
their scans were experienced as reassuring the possible harm was soon forgotten. It is my 
judgement that this experience was within the range of acceptable risks in this kind of 
research, but it is none the less an experience that illustrates the vulnerability that can be 
triggered within the frame of the health discourse that makes people individually responsible 
for their own health. This in a sense reflects the finding from another study, showing that 
thoughts about osteoporosis can be fear-arousing in themselves (Hvas, et al. 2005). 
 The other ethical challenge we experienced concerns the confidentiality among the 
group participants. As described in the methods section the women were asked to sign a 
declaration of confidentiality, in an effort to instill confidence in the exclusive use of the 
material for research purpose only. For this project that procedure was accepted by REK. 
When we designed a similar study a few years later, the declaration of confidentiality among 
research participants was not accepted on the grounds that it did not have any legal 
consequences. Whereas we as researchers could be subject to prosecution if we were to break 
the confidentiality rules, no such sanction could be executed if the participants were to do the 
same. REK therefore argued that the signing of the declaration would create a sense of false 
reassurance about confidentiality among the participants. We accept this as a legally valid 
argument, but it does not solve the ethical challenge in the matter. How can we act to ensure 
the confidentiality issue among the group members? The only answer we have found to this 
issue is that we cannot give the participants any guarantees of mutual confidentiality. In 
subsequent projects we have made this point explicit to the group members, much in line with 
Tolich’s (2009) argument for practising the principle of caveat emptor in focus group research. 
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FOR BETTER, FOR WORSE - FINAL REFLECTIONS 
Having discussed the findings from my sub-studies earlier, I now return to some more general 
issues which also belong among the reflections on risk, medicalization and osteoporosis. Both 
Clarke, et al. (2010) and Conrad (2007) stress that their contributions are limited to the USA. 
A brief reflection on the situation in Norway is therefore offered. Furthermore, the medical 
discourse on risk is so dominant it can be easy to forget its alternatives. Some alternatives are 
therefore presented, as a reminder. Lastly we turn to some of the dilemmas risk medicine is 
facing us with, facing us with the act of balancing good and bad. 
 
Lay acceptance and professional resistance 
An observation about medicalization in Norway is that we are witnessing wide acceptance 
among the lay populace and pockets of resistance among the medical profession. 
Valuable insight about the medicalization of everyday life in Norway has come from a 
longitudinal study over three decades in a small coastal community in Northern Norway 
(Anderssen, 2010). Starting in the 1980s these observations describe a community that was 
fairly isolated from medical influence. Modernization, including improved transportation, 
opened this society for medicalization through surveillance medicine in the 1990s. This was 
met with both gratitude and resistance. In the 21st century, however, medicalization had 
become the norm and was an integrated part of everyday life in this community. The study 
illuminates how medicalization over time becomes the status quo that everyone takes for 
granted. 
 As noticed in Papers III, IV and V, the medicalization of osteoporosis has been 
welcomed among the lay people involved in those sub-studies as an effort to improve 
women’s health. A possible explanation for this is that it is perceived as a form of desirable 
medicalization, serving a feminist purpose (Purdy, 2001). Unfortunately, their notion of a 
feminist triumph also signalled a common misconception, reflecting the underestimation of 
their own risk of CHD, which is not uncommon among women (Ruston & Clayton, 2002; 
Frich, Malterud & Fugelli, 2007).  
 In Paper IV we also mentioned the activities of the Norwegian Women’s Public 
Health Association (NWPHA). Their contribution can be seen as that of a consumer group 
73 
 
organizing what they see as a valuable health service for women. By doing so, they have 
contributed to mammography before a national screening programme was established, and 
also contributed to bone density screening. This illustrates how medicalization has come as an 
outcome of an alliance between feminist stakeholders and private entrepreneurs within the 
medical profession. This alliance can therefore be seen as having similarities to those 
established during the Fosamax-case (Paper III), in an effort to bypass the health authorities’ 
attempt to limit some forms of medicalization. 
 Within the ranks of professional medicine, there are not only entrepreneurs thriving on 
medicalization, but also pockets of resistance. The publication of Paper I coincided with what 
the Norwegian Society of General Practitioners (NSAM) called their “risk project”. This 
project was started in 1994 with the aim of contributing to more and better reflections about 
the risk concept in medicine (Swensen, 2000a). It was based on critical reflections about the 
challenges general practitioners faced in clinical practice when meeting people ‘at risk’ of 
various diseases. Among these critical reflections was also a concern about the medicalization 
of people who perceived themselves as healthy. Their project was thus an effort to curb what 
they saw as a potentially negative development in medicine. The critical reflections in the 
project were summarized in an anthology (Swensen, 2000b).  
 Another accomplishment of the Norwegian general practitioners behind this project 
was a petition against the 1999 WHO guidelines on hypertension. The petition was published 
internationally on the internet and national in Norwegian newspapers. More than 400 doctors 
from 42 countries signed the internet petition which was sent to WHO Director-General, Gro 
Harlem Brundtland (Woodman, 1999). 
 Academically this Norwegian resistance against medicalization peaked with the 
publication of a series of articles that were to become the doctoral thesis of Linn Getz (2006). 
Briefly summarized, these articles problematized the outcomes when clinical guidelines were 
paired with epidemiological data about what could be seen as one of the healthiest 
populations that has ever been around. Ethical concerns were thus raised relating to what was 
seen as a wrong turn in modern medicine. Closely related to the Norwegian efforts has been 
the establishment of the Nordic Risk Group, which has also accomplished the publication of 
an anthology with texts critical of medicalization (Brodersen, et al. 2009). Despite the 
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dedication of these professionals it can also be seen as based on limited resources compared to 
its perceived adversaries.  
 Much of the mentioned resistance has been focused on clinical guidelines as tools of 
medicalization of the healthy part of the population. It may thus be seen as a paradox that 
some of the critics have recently contributed to the development of Norwegian guidelines on 
the prevention of cardiovascular diseases, with the option of using statin treatment as a 
measure of primary prevention (Norheim, et al. 2011). Through the story about the process 
behind the guidelines, its authors have strived for a transparent process, indicating that the end 
result is a compromise between general practitioners and hospital experts. Although the group 
also has patient representatives and a representative from the health authorities among its 
members, their role is less clearly described. It can be seen as a form of medicalization 
through democratization, rather than the form of medicalization by experts when such 
guidelines normally are negotiated. A possible conclusion from the above is that efforts have 
been put into limiting what the critics may see as more devastating forms of medicalization. 
The resistance against medicalization may thus be seen as losing ground.  
 These examples, and many more that could be given, illustrate that medicalization 
through the application of knowledge about risk has become an established part of the 
Norwegian society. Its demedicalization thus seems highly unlikely. It is still interesting to 
note, however, that there are alternatives within the frame of medicalization that are worth 
looking into.  
 
It could have been different 
The medical risk discourse has become a dominant way of constructing matters of health and 
illness. Its dominance may lead us to think that it represents the only way of constructing 
these issues. As indicated earlier, history and culture can provide us with valuable food for 
reflections about how things could have been different. Hopefully I have also been able to 
show in the previous discussion that our ‘reality’ is not developing in a deterministic fashion. 
If the medical risk discourse represents the ‘status quo’ of our present situation, it may help 
our critical reflections about it if we also take into consideration some alternative discourses. 
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 One noticeable part of the medical risk focus is that it has a heavy individualistic bias. 
As a consequence the responsibility in matters of health and illness is attributed to the 
individual. This relates to the concept of calculative rationality, where a healthy citizen 
behaves in accordance with available risk information. In this sense the risk discourse can be 
seen as being based on what in social psychology is known as ‘the fundamental attribution 
error’, reflecting preference for individualized explanations over contextualized ones.  
 The latter set of explanations would lead us to focus more on the rich literature on the 
influence of socioeconomic status on health. Such a focus would take us away from the 
medical gaze towards the nonmedical determinants of health (Mechanic, 2007). It is perhaps 
telling when we find the medical literature on osteoporosis and socioeconomic factors to be 
literally non-existent. Despite that there have been observed large disparities in the fracture 
risk around the world, this has triggered little interest in the structural factors behind these 
numbers. Instead the dominant view in the osteoporosis literature seems to be that differences 
in race and ethnicity are the major explanation for the disparities. As a consequence a major 
feature of FRAX is that it is based on a growing number of reference groups in countries 
around the world, supposed to reflect the effect of race and ethnicity on fracture risk (Kanis, 
et al. 2010). This is not only a development that can be seen as ignoring the impact of 
socioeconomic factors on osteoporosis, but also one that has been criticized for lacking a 
theoretical foundation in biology (Fausto-Sterling, 2008). These critiques resonate well with 
the early medicalization critique, which claimed that medicine took the focus away from 
social problems by offering individual solutions at the patient level. If the key to the 
prevention of osteoporosis is building peak bone mass, then the solution is hardly BMD 
screening and bisphosphonates. Building peak bone mass may have much wider implications 
though, as it clearly challenges certain lifestyles. Its achievement would surely involve the 
medicalization of everyday life, but not pharmaceuticalization. 
 Another alternative to the medical risk discourse has been offered through the concept 
of local biologies, acknowledging that what in biomedicine is understood as universally 
biological is constructed differently across cultures. This is indicated by the differences in 
perceived symptomatology among middle aged Japanese and North American women (Lock 
& Kaufert, 2001). Offering an explanation related to the work ethic of Japanese women as one 
not allowing time “for succumbing to an illness associated with luxury and indolence” (Ibid, p. 
502), resonates with the situation described earlier among Scottish women (Backett-Milburn, 
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Parry & Mauthner, 2000) and to a certain extent the participants of our focus groups (Paper 
IV). It furthermore also resonates with Porter’s (1997) rhetorical question about our status as 
hypochondriacs. If life does not leave time for handling symptoms, then bothering about the 
asymptomatic things in life makes little sense.  
 Among the strong appeals of the risk discourse is our perceived ability to control 
matters of life and death. Another observation that crosses the medical risk discourse is the 
role that luck still can be seen as playing in our lives (Fredriksen, 2005). This leaves room for 
such factors as place of birth, genes, environments, epidemics and accidents as playing vital 
roles in our lives. Such factors go along with the social epidemiology mentioned above, in 
undermining the validity of the discourse that portrays us as the masters of our own fate. 
Ironically this has been shown to be part of ‘lay epidemiology’(Davison, Smith & Frankel, 
1991), which has been shown to offer more sophisticated observations about life than the 
arbitrary dichotomies of the risk/no risk – high risk/low risk format. It has furthermore been 
argued that a better way to address matters of health and illness comes through the 
salutogenetic approach focusing on people’s health resources rather than their health risks 
(Malterud & Hollnagel, 2000).  
 All the alternative discourses mentioned above can be seen as being within the frame 
of the medicalization of everyday life. Still, their intuitive appeal lies in the argument that 
there are problems that would be better dealt with by other means than pills, implying that 
some kinds of medicalization are better than others (Busfield, 2006). 
 
For better, for worse 
In this closing part of the thesis I take the opportunity to make some ethical reflections, as 
ethical concerns are among the major motivations for performing the research in this thesis. 
By doing so I take it for granted that we seek to make the human condition better and avoid 
making it worse when there is a clear choice between the two. As risk carries the potential for 
spending resources (including personal worry) on something that may never happen, the 
choice between better and worse is somewhat muddled when risk is involved. 
Knowledge about risk is supposed to be a good thing, because it offers the opportunity 
of controlling fate. Therein lies its potential for making our lives better. It can, however, also 
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be a constant reminder of our frailty. The proponents of a risk factor based preventive 
medicine have tended to take the first possibility for granted, ignoring the second. This has 
contributed to a situation wherein knowing your risk has become an imperative. As a 
consequence of this imperative the sharing of such knowledge has become both a professional 
duty and a consumer right. We may do well to sit back and reflect on both sides of the table 
whether this is really what we want. 
 Another good thing would be to acknowledge that we do not know what our response 
to knowledge about our personal risk will be. As it has both the potential for making our lives 
better and worse, we should be prepared for both options. It should therefore be part of the 
information given before people make the decision about undergoing various forms of 
medical testing aimed at calculating their risk. In the Norwegian Biotechnology act this is 
acknowledged when it comes to genetic risk information. This law is based on the idea of 
‘genetic exceptionalism’, based on the belief that genetic risk information is qualitatively 
different from other risk information (Green & Botkin, 2003). If recent developments in 
genetics teach us that this is not necessarily the case, we may also do well to reflect on 
whether the practice hitherto reserved for genetic tests should also be applied in other areas of 
risk testing. 
 Screening comes with a built-in dilemma that puts us in the position of being damned 
if we do and damned if we don’t. There will always be room for regret. Being informed about 
your health risk carries the possibility that you may regret it if it changes your life for the 
worse. On the other hand, if you choose to abstain from screening and you later discover that 
you have the disease screened for, there will be another reason for regret.  
 Even if the test result is negative, there is always the possibility that it can change. 
Herein lays perhaps the strongest potential for medicalization that is provided by risk factors. 
There is no way that the patient with confidence can know their own health status, as there are 
no signs to observe. Once the idea of the symptom free body as a source of risk has been 
accepted, there is only one thing to be sure of – you can never be sure. 
Another potential problem of risk-based medicine is that the different risks tend to be 
seen in isolation. As illustrated in Paper VI the idea of the Polypill has been introduced with 
the prospect of reducing the risk of cardiovascular disease by more than 80 % (Wald & Law, 
2003). It has also been suggested that  bisphosphonates also could be added as another 
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ingredient, to make it work against osteoporosis as well (Greene, 2007). As immortality is still 
outside our reach, we should perhaps ask what other risks we opt for by taking the Polypill. A 
possible consequence could be that the Polypill-boxes should be labelled with warnings about 
the increased risk of cancer that will follow from taking it. 
 Much of the current discussion about the ethical challenges of risk medicine has 
revolved around treating healthy, asymptomatic individuals as if they were already sick 
through the construction of ‘at risk’ individuals. Lately, concerns have also been aired as to 
what is happening when the notion of risk is entering in the other end of life. This is 
illustrated by how implantable cardiac cardioverter defibrillators (ICDs) have come to be used 
in patients who have not yet had a cardiac event (Shim, Russ & Kaufman, 2006). In the 
ethical reflections about risk-reducing medicine, it is thus important to remember that there 
are limits to what should be done even if they are doable. This is perhaps the most important 
limit to risk-based medicalization. 
 
Future research 
As noted in my methodological reflections one of the weaknesses of this thesis is that all its 
sub-studies can be seen as areas in need of more in-depth studies. The risk epidemic for one 
thing begs for a closer examination as to looking behind the face value of the increasing 
number of articles. 
 As for osteoporosis there are a number of issues that need looking into. The 
development of FRAX is among the obvious candidates, both when it comes to scrutinizing 
the understanding of the relation between osteoporosis and race/ethnicity, and the current 
devaluation of BMD as a risk factor for osteoporosis. Making risk assessment freely available 
by means of modern internet technology is another issue that offer new options. 
 Our present knowledge about the consequences of being screened for osteoporosis is 
restricted to studies in populations that participate in health surveys. To gain further insight 
into the experiences of people who have bone scans outside this context will be another 
source of new insights. Such studies would also benefit from more longitudinal designs, 
covering both the short term and long term impact of bone scans. 
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Concluding remarks 
The ultimate goal of research is to change the human condition for the better. How this is 
achieved in social science is not always obvious. By sharing my reflections on the themes 
covered in this thesis I hope to have offered new insights into these matters. Hopefully I have 
been able to demonstrate that things are more complex than they seem at first. Medicalization, 
for one thing, has become much more complex since the original medicalization critique was 
introduced.  
 During this research I have also discovered that osteoporosis provides a most 
fascinating case for studying both the impact of the risk concept in medicine and the 
development of medicalization. Much attention has been given to the risk factors associated 
with coronary heart disease, but osteoporosis is a social construction deserving of just as 
much attention. On this matter I agree totally with our study participants. 
 It is further worth noting that medicalization happens because it makes sense to a lot 
of people. This is to a large degree so because the scientific study of risk provides it with a 
strong foundation. As I have also hopefully been able to illuminate, medicalization is an on-
going process, just like life itself. Thereby it provides us with ample opportunity for further 
studies and lived experiences, becoming an integrated part of our lives and hence ourselves.  
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